Articles & News
-
Psychiatry stripped naked: Current human rights violations in
psychiatry in Germany, Greece and the rest of the world, by
Peter Lehmann, Journal of Critical Psychology,Counselling and
Psychotherapy, Vol. 24, No. 1, 16-37 (2024).
-
New Federal Guidance for Alternatives to Police for People with
Behavioral Health or Other Disabilities, by Judge Bazelon
Center for Mental Health Law and Vera Institute Justice, January
14, 2025.
-
When There’s a Crisis, Call a Peer: How People with Lived
Experience Make Mental Health Crisis Services More Effective,
Judge Bazelon Center for Mental Health Law, January 3, 2024.
-
Report on Improving Mental Health Outcomes, by James B. (Jim)
Gottstein, Esq.; Peter C. Gøtzsche, MD; David Cohen, PhD; Chuck
Ruby, PhD; Faith Myers, September, 2023.
-
OPINION: The rights of Alaskans with mental illness are being
violated – by the state, the courts and their own attorneys,
Val Van Brocklin, Anchorage Daily News, April 3, 2023.
-
Letter to United
States Senators Wyden and Crapo regarding their Unmet Mental
Health Needs Request for Information, November 1, 2021.
-
Video:
Soteria Past, Present, and Future: The Evidence For This Model
of Care, by Robert Whitaker, July 16, 2021.
-
Relief
for Acute Psychotic Experiences: Stabilizing Homes - The Soteria
Model, National Associatioin on Mental Illness Washington
2021 State Conference October 16 2021.
-
What Happened to Britney Spears can Happen to You, by Jim
Gottstein, RxISK, August 2, 2021.
-
A
conversation on Britney Spears, conservatorship, and psychiatric
power, Laura Delano, David Cohen, PhD, & Jim Gottstein, June
28, 2021.
-
Meta-analysis of the strength of exploratory suicide
prediction models; from clinicians to computers, by Corke,
M., Mullin, K., Angel-Scott, H., Xia, S., & Large, M.
(2021).
-
Prohibition of Involuntary Hospitalization and Involuntary
Treatment: Countering Misapprehensions-- A briefing paper
addressed to the Committee on the Rights of Persons with
Disabilities and other stakeholders, by Tina Minkowitz, July
13, 2020.
-
Systematic violations of patients’ rights and safety: Forced
medication of a cohort of 30 patients, by Peter C Gøtzsche and
Anders Sørensen, Indian Journal of Medical Ethics Online First
Published August 12, 2020.
-
MindFreedom International Organizing Guide for Psychiatric Survivors.
-
Treatment Planning and Medication Monitoring Were Lacking for
Children in Foster Care Receiving Psychotropic Medication, by
the Office of the Inspector General, U.S. Department of Health and
Human Services, September 17, 2018.
-
Psychotherapy
v. Medications: Let us Court the Ways, National Alliance of
Professional Psychological Providers, Feb, 2017, Vol 12 No. 2.
-
"Prior
psychiatric treatment was the single strongest predictor of suicide
death," J.D. Ribeiro, J.C. Franklin, K.R. Fox, K.H. Bentley,
E.M. Kleiman, B.P. Chang, and M.K. Nock, Letter to the Editor,
Psychological Medicine, 46 (2016).
-
Opinion:
Misguided mental health system needs an overhaul, by Jim Gottstein,
January 13, 2016, Alaska Dispatch News.
-
Escape from British Columbia, Rob Wipond, Focus,
November-December, 2016.
-
The Case Against Antipsychotics: A Review of Their Long-term Effects,
by Robert Whitaker, Mad In America Foundation, July, 2016.
-
Open dialogues in the present and the future – new developments,
byJaakko SeikkulaMay 13, 2016.
-
The Search for Schizophrenia Genes: Larger and larger samples are
showing smaller and smaller effect sizes. What does this mean for
drug development, clinical practice, and our view of mental illness?
by Jonathan Leo, Slate, February 5, 2016.
-
PsychRights and Committee for Truth in Psychiatry submission to FDA
opposing reclassification of electroshock machines, March 25,
2016.In search of an evidence-based role for psychiatry, by John
Read, Olga Runciman, & Jacqui Dillon, Future Science,
February 22, 2016 (online).
-
Soldiers Of The Iraq/Afghanistan Era Dead Of Sudden Cardiac Death
Probably Due To Prescription Antipsychotic & Other Psychotropic
Drugs, by Fred A. Baughman, Jr., MD, Presented at the 22nd
Annual Combat Stress Conference May 1-3, 2015 Carlsbad, CA.
-
Drugging
Our Kids: Children in California’s foster care system are prescribed
unproven, risky medications at alarming rates, story by Karen De
Sa, San Jose Mercury News, August 25, 2014.
-
Feds Pay for Drug Fraud: 92 Percent of Foster Care, Poor Kids
Prescribed Antipsychotics Get Them for Unaccepted Uses, by Art
Levine, Huffington Post, April 30,2015.
-
Letter From Nine Mental Health Experts To Funders And Ethics
Committee About Ketamine + Electroshock Therapy Study, John
Read Blog, June 21, 2014.
-
Revisiting a debate: Does psychiatry overmedicate? by Stacey
Burling, The Philadelphia Enquirer, April 10, 2014.
-
The Drugging of the American Boy, Esquire, by Ryan
D'Agostino, March 27, 2014.
-
Department
of Justice letter stating askin about psychiatric diagnosis on bar
application violates federal law, January 21 2014.
-
Barry Pollack letter to
the Commissioner of the Massachusetts Department of Mental Health
regarding the abuses by Boston Children's Hospital at its Bader 5
psychiatric ward, December 21, 2013.
-
A psychiatrist thinks some patients are better off without
antipsychotic drugs, by Sandra Steingard, The Washington
Post, December 9, 2013.
-
J.&J. to Pay $2.2 Billion in Risperdal Settlement, by Katie Thomas,
The New York Times, November 4, 2013.
-
Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal
and Civil Investigations Allegations Include Off-label Marketing and
Kickbacks to Doctors and Pharmacists, Department of Justice,
November 4, 2013.
-
Doctors:
Anti-psychotic meds overused for dementia, kids, USA Today,
September 21, 2013.
-
Seventh Circuit Rules
Psychiatrists Commit Medicaid Fraud By Prescribing Psychiatric Drugs
Off-Label to Children, August 29, 2013.
-
Opinion in
Ex rel
Watson v. King-Vassel, August 28, 2013.
-
U.S. Probes Use of Antipsychotic Drugs on Children,
by Lucette Lagnado, The Wall Street Journal,
August 11, 2013.
-
A
Nation of Kids on Speed: Six million children in the
U.S. have already been diagnosed with ADHD. Plenty more
will follow,by Pieter Cohen and Nicolas Rasmussen,
The Wall Street Journal, June 16, 2013.
-
Medicare Drug Program Fails to Monitor Prescribers,
Putting Seniors and Disabled at Risk, by Tracy
Weber, Charles
Ornstein and Jennifer
LaFleur ProPublica, May 11, 2013.
-
Psychiatry’s Guide Is Out of Touch With Science, Experts
Say, by Pam Belluck & Benedict Carey, The New
York Times, May 6, 2013.
-
May 3, 2013,
Complaint in Marcus Class Action Against Forest Labs
about pediatric use of Lexapro.
-
Dangerous Meds for Children Constitute Medicaid Fraud,
by Salvatore Pizzuro, April 29, 2013 The New Jersey
Newsroom.
-
US sues
Novartis in NY again, cites doc kickbacks, April 26,
2013, Associated Press.
-
Updated list of Soldiers/Veterans Dying of Probable
Sudden Cardiac Death, by Fred Baughman, MD, April
17, 2014.
-
Psychiatric Asbos' (Outpatient Commitment) were an error
says key advisor: Former champion says public safety
fears led to adoption of measures that seriously
curtailed patients' freedoms, The Independent,
April 14, 2013.
-
Statement by Mr. Juan E Méndez, Special Rapporteur On
Torture And Other Cruel, Inhuman Or Degrading Treatment
Or Punishment, 22nd session of the Human Rights
Council of the United Nations, March 4, 2013, Geneva.
-
The Op-Ed: Antidepressants & Controversial Studies,
by Ed Silverman, Pharmalot, February 11, 2013.
-
PsychRights'
Open Letter to Senator Lisa Murkowski (R Alaska), January
21, 2012.
-
Suicidal Teens Plagued by Improper Treatment Strategies,
by Elizabeth Lopatto, Bloomberg News, January
09, 2013.
-
Psychiatrist Goran Isacsson withheld and destroyed
unwanted research data about antidepressants and suicide,
by Janne Larsson, January 3, 2013.
-
PsychRights' Letter to the President's Task Force on Gun
Violence, January 7, 2013.
-
Predicting violence is a work in progress, by David
Brown, The Washington Post, January 3, 2013.
-
Suggestions to the Human Rights Committee for
disability-related questions to consider for its List of
Issues for the United States, December 28, 2012,
from the Center for the Human Rights of Users and
Survivors of Psychiatry (CHRUSP), Law Project for
Psychiatric Rights (PsychRights), Voices of the Heart,
Mind Freedom International, Repeal Mental Health Laws,
World Network of Users and Survivors of Psychiatry
(WNUSP) and International Disability Alliance.
-
Adult antidepressants suspected in suicides of Canadian
kids, by Jesse McLean, David Bruser, Toronto
Star, December 8, 2012.
-
Psychiatry beyond the current paradigm, by Pat
Bracken, Philip Thomas, Sami Timimi, Eia Asen, Graham
Behr, Carl Beuster, Seth Bhunnoo, Ivor Browne, Navjyoat
Chhina, Duncan Double, Simon Downer, Chris Evans, Suman
Fernando, Malcolm R. Garland, William Hopkins, Rhodri
Huws, Bob Johnson, Brian Martindale, Hugh Middleton,
Daniel Moldavsky, Joanna Moncrieff, Simon Mullins, Julia
Nelki, Matteo Pizzo, James Rodger, Marcellino Smyth,
Derek Summerfield, Jeremy Wallace and David Yeomans,
British Journal of Psychiatry, 201,430–434 (2012).
-
Time to rethink mental health laws for treatment without
consent, by Bernadette McSherry, of
Monash University, in The
Conversation.
-
Antipsychotic Use Spikes in Medicaid-Enrolled Children,
by Heidi Splete, Clinical Psychiatry News,
October 3, 2012.
-
First Risperdal Trial Ends With Settlement, by
Amaris Elliott-Enge, The Legal Intellegencer,
October 5, 2012.
-
The
drugs don't work: a modern medical scandal. The doctors
prescribing the drugs don't know they don't do what
they're meant to. Nor do their patients. The
manufacturers know full well, but they're not telling,
by Ben Goldacre, The Guardian, September 21,
2012.
-
Psychiatric training and treatment under the microscope,
by Jan Petter Myklebust, University World News Global
Edition, September 16, 2012.
-
Raising the Ritalin Generation, by Grownwen Hruska,
The New York Times, August 18, 2012.
-
More Kids Taking Antipsychotics for ADHD: Study, by
Steven Reinberg, HealthDay,
Aug. 07, 2012 -
Two Who Resigned From DSM-5 Explain Why, July 11,
2012, Psychology Today.
-
Glaxo Agrees to Pay $3 Billion in Fraud Settlement,
by Katie Thomas and Michael S. Schmidt, The New York
Times, July 2, 2012.
-
4-year-old Texas girl taken from parents and heavily
drugged by Child Protective Services, May 18, 2012,
RT News.
-
'Label jars, not people': Lobbying against the shrinks,
by James Davies, May 17, 2012.
-
3-year-old in CPS' care overprescribed psychotropic drugs, Fox News
Houston, May 16, 2012.
-
Abbott Laboratories to pay $1.6 billion over misbranding
drug, b Terry Frieden, CNN Justice Producer, and Tom
Watkins, CNN, May 7, 2012.
- Video:
Mind Over Meds, Part 1, KTUU, Anchorage, Alaska NBC
affiliate, May 7, 2012.
- Video:
Mind Over Meds, Part 2, KTUU, Anchorage,
Alaska NBC affiliate, May 8, 2012.
- Video:
Mind Over Meds, Part 3, KTUU, Anchorage, Alaska NBC
affiliate, May 9, 2012.
- Video:
Mind Over Meds, Part 4, KTUU, Anchorage, Alaska NBC
affiliate, May 9, 2012.
- Video:
Why are soldiers dying in their sleep? ABC 11
News, Raleigh-Durham, North Carolina, April 26, 2012.
-
Evidence shows that anti-depressants likely do more harm
than good, researchers find, McMaster University,
April 24, 2012.
-
SSRI Benefit in Autism May be Overstated, by Todd
Neale, MedPage Today, April 23, 2012.
- PowerPoint:
The Mental Health System: Who's Crazy, Jim Gottstein
presentation at the Wilda Marston Theater, Anchorage,
Alaska April 10, 2012.
-
A fog of drugs and war:
More than 110,000 active-duty Army troops last year took antidepressants,
sedatives and other prescription medications. Some see a link to aberrant
behavior, by Kim Murphy, Los Angeles Times, April 7, 2012.
- Video:
Jim Gottstein on the Dan
Fagan Show (starting 53 minutes in), April 5, 2012.
-
Keeping
America’s Children Safe From Abuses In The Use Of Psychotropic Drugs And
Seclusion/Restraint, National Association of County Behavioral Health &
Developmental Disability Directors, April 1, 2012.
- 30 Minute Video:
"Drugging
Our Children: Legal and Moral Issues," March 29, 2012, talk by
James B. (Jim) Gottstein, Esq., to the American
Psychological Association Humanistic Division (Div. 32)
annual conference.
- 9 Minute Video:
The Psychiatric Drugging of Children & Elderly, Jim Gottstein
discussing the psychiatric drugging of children and youth and the
elderly at his guest lecture at Alaska Pacific University, February
22, 2012.
- Doctors not fully told of downside of antipsychotic
drugs, study finds: A new report finds that
psychiatrists have not been given a full picture of the
effectiveness, or lack thereof, of so-called atypical
antipsychotic drugs, by Brian Vastag, The
Washington Post, March 21, 2012
-
Antipsychotic drugs grow more popular for patients
without mental illness, by Sandra G. Boodman, The Washington Post, March 12, 2012.
-
Are Psychiatric Medications Making Us Sicker? John
Horgan, Scientific American, March 5, 2012.
- Opinion:
Ritalin Gone Wrong, by L. Alan Sroufe,
The New
York Times, January 28, 2012.
- Powerful Psychiatrists Push False Theory on Unknowing
Souls, by Paula Caplan, PhD, Psychology Today,
January 24, 2012.
-
Psychiatric Group Push to Redefine Mental Illness Sparks
Revolt, by Elizabeth Lopatto, Bloomberg News,
January 24, 2012.
-
Depression drugs ‘causing falls’ Elderly people with
dementia are more likely to suffer falls if they are
given anti-depressants by care home staff, a study
claims, BBC News, January 18, 2012.
-
U.S. to Force Drug Firms to Report Money Paid to Doctors,
by Robert Pear, The New York Times, January 16,
2012.
-
False Claims, Off-Label Prescribing & DoctorsFalse Claims, Off-Label Prescribing & Doctors, by Ed
Silverman, Pharmalot, December 21, 2011.
- Down the Hatch: The Texas Attorney General's Office says
a drugmaker lied in order to push an antipsychotic on
foster children. So why are kids as young as three still
taking the drug? By Craig Malisow published,
December 15, 2011.
-
Oregon sees drop in the number of foster kids who get
psychiatric drug prescriptions, by Michelle Cole,
The Oregonian, December 07, 2011
- 20/20
Overmedication in Foster Care, December 2, 2011.
- Video:
United States Senate Hearing on
The Financial And Societal Costs Of Medicating
America’s Foster Children, in the Subcommittee on Federal Financial
Management, Government Information, Federal Services,
and International Security, December 1, 2011.
- New
Study Shows U.S. Government Fails to Oversee Treatment
of Foster Children With Mind-Altering Drugs, Diane
Sawyer, ABC News, November 30, 2011.
- United States Department of Health and Human Services
letter to state Medicaid Directors regarding
psychotropic drugs given to children and youth in foster
care, November 23, 2011.
-
Drugs Used for Psychotics Go to Youths in Foster Care,
by Benedict Carey, The New York Times, November
20, 2011.
-
9th Circuit
Allows Fraud to Continue; PsychRights Expects To File for Rehearing,
October 25, 2011.
-
PsychRights Defends Its Whistle-Blower Status, by
June Williams, Courthouse News, October 20,
2011.
-
Audio of Oral Argument
before the United States 9th Circuit Court of Appeals,
in
PsychRights v. Matsutani,
October 12,
2011.
-
Rising Mortality Rates for People with Serious Mental
Illness, The NeuroCritic, October 11, 2011.
-
Military continues off-label drug use, despite concerns,by
Bob Brewin, NextGov, September 28, 2011.
-
U.S. advisers urge FDA to address antipsychotics in kids,
by Alina Selyukh, Reuters, September 22,
2011.
-
Baby deaths spark fears over antidepressants Deaths
unexplained; Effexor cited as possible contributor,
risk factor, by Kathy Tomlinson, CBC News,
September 20, 2011.
-
Are Psychiatric Medications Making Us Sicker? by
Dave Plunkert for The Chronicle Review,
September 18,2011.
- Jim Gottstein's 2011 NARPA PowerPoint Presentation on "PsychRights'
Litigation Against the Psychiatric Drugging of Poor Children & Youth."
-
Has Psychiatry Been Corrupted Beyond Repair? fake science is causing
real harm, by John D. Gartner, Ph.D, Psychology Today,
September 15, 2011
-
Full Disclosure Needed About Psychiatric Drugs That Shorten Life
Research Shows Some Psychiatric Drugs Decrease Lifespan, by
Paula J. Caplan, Ph.D. in Science Isn't Golden Published, Psychology
Today, September 4, 2011
- VA
spent $717 million on a drug deemed as effective as a placebo,
by Bob Brewin NextGov,
August 22, 2011.
- Speakers bureau
formed to oppose electroshock treatments in Ontario, by John
Bonnar, August 18, 2011.
- Major Increase
in Hospitalization Rates for Children with Psychiatric Disorders
Released, Stony Brook University Medical Center, August 11,
2011.
- Drugs Found Ineffective for Veterans’ Stress, by Benedict Carey,
The New York Times, August 2, 2011.
- AstraZeneca Settles Most Seroquel Suits, by Duff Wilson,
The
New York Times, July 28, 2011.
- Useless
Studies, Real Harm, Opinion by Carl Elliott, The New York
Times, July 28, 2011.
-
Drug firms paid 'independent' experts Practice led to
AG-whistleblower lawsuit, by Nanci Wilson, KXAN Austin,
July 25, 2011.
- AstraZeneca to Face 2012 Trial in Arkansas Over Sales of
Anti-Psychotic, By Sonny Rhodes and Jef Feeley - July 18,
2011
- 'Nobody cared'
about her son — until he hanged himself, by
Diana Zlomislic, Totonto News, July 14, 2011
- Mass psychosis in
the US: How Big Pharma got Americans hooked on anti-psychotic drugs,
by James Ridgeway, Al Jazeera, July 12, 2011.
-
Complaint of Scientific Misconduct against Dwight L. Evans, Laszlo
Gyulai; Charles Nemeroff, Gary S. Sachs and Charles L. Bowden,
to the United States Office of Research Integrity, July 8, 2011.
-
Was the order removing Godboldo's daughter from her custody valid?
WXYZ, Channel 7, July 7, 2011.
- Response to the American Psychiatric Association: DSM-5 Development,
by British Psychological Association June, 2011.
- The
Illusions of Psychiatry, by Marcia Angell, The New York
Review of Books, July 14, 2011.Detroit Action News,
- The Epidemic of Mental
Illness: Why? June 23, 2011.
- GPs have been urged to review all patients with dementia
taking antipsychotic drugs to reduce potential harm from
inappropriate prescribing, by Stephen Robinson, GP Magazine, (UK) June 9, 2011.
- Judge orders Johnson & Johnson subsidiary to pay SC $327
million for deceptive drug marketing, by Meg Kinnard,
Associated Press, June 3, 2011.
-
America's Most Dangerous Pill? by Christopher Byron,
The Fix, AlterNet, June 1, 2011.
-
Getting personal: Feds pursue top execs in health care
fraud cases previously settled for cash, by
Associated Press, Published, May 30
-
Creating juvenile zombies, Florida-style, by Fred
Grimm, The Miami Herald, May 28, 2011.
-
Drugging the Vulnerable: Atypical Antipsychotics in
Children and the Elderly, By Mala Szalatitz, Time
Magazine, May 26, 2011.
-
Palm Beach Post Exclusive: Jailed juveniles' doctors
draw Medicaid inquiry -- Drugging juveniles: Doctors
hired to evaluate kids in state custody have taken huge
payments from drug companies, by Michael Laforgia,
The Palm Beach Post, May 25, 2011.
-
Nearly Half of Kids in Inpatient Psychiatric Program
Receive Antipsychotics, by Arline Kaplan,
Psychiatric Times, May 23, 2011.
-
Huge doses of potent antipsychotics flow into state
jails for troubled kids. Drugging juveniles:
Doctors hired to evaluate kids in state custody have
taken huge payments from drug companies, by Michael
Laforgia, The Palm Beach Post, May 22, 2011.
- Plea to free children from 'chemical cages', by
Andrew Taylor, The Sydney Morning Herald, May 15,
2011
-
A bitter pill: from depression to obesity, by Mark
Metherell, The Sydney Morning Herald, May 14,
2011
-
Highlighting Drug Industry Influence, Watchdog Says
Overmedication in Nursing Homes Is Troubling, by
Marian Wang, ProPublica, May 10, 2011.
-
Overmedication of Nursing Home Patients Troubling, Statement by
Daniel R. Levinson, Inspector General, Department of Health and
Human Services, May 9, 2011
- Medicare
Atypical Antipsychotic Drug Claims For Elderly Nursing Home
Residents, Report by Daniel R. Levinson, Inspector General,
Department Of Health And Human Services, Office Of Inspector
General, May, 2011.
- Antipsychotic Drugs Called Hazardous for the Elderly,
by Gardiner Harris, The New York Times, May 9,
2011.
-
So
Full of Fail, Disability Rights Center of Arkansas,
May 9, 2011.
-
Changes To Reimbursement Rules For Prescribing
Psychotropic Medications: Small Changes That Can
Significantly Reduce Total Healthcare Costs While
Increasing The Quality of Care For Patients, by the
National Alliance Of Professional Psychology Providers,
May, 2011.
-
One in four ADHD sufferers 'fake or exaggerate' symptoms
for drugs to get high or raise focus, The Daily
Mail, April 26, 2011.
-
FOIA Friday: The NIH Reacts to "Show Me the Money!"
Researcher, Project on Government Oversight,
April 22, 2011.
-
Strategies
and Practices in Off-Label Marketing of Pharmaceuticals:
A Retrospective Analysis of Whistleblower Complaints,
by Aaron S. Kesselheim, Michelle M. Mello, David M.
Studdert, PLoS
Medicine, April 2011, Vol 8, Issue 4.
-
July
30, 2009, letter from National Institute of Mental Health to Emory
University.
- The STAR*D Scandal, by
Ed Piggot, Ph.D., Mad in America Blog, April 20, 2011.
-
STAR*D: A Tale and Trail of Bias, by H. Edmund Pigott, PhD,
Ethical
Human Psychology & Psychiatry, Vol 13. No. 1:6-28 (2011)
- Link Between Antidepressant Use And Thicker Arteries,
Medical News Today, April 3, 2011.
-
Study Finds Conflicts Among Panels’ Doctors, by Duff
Wilson, The New York Times, March 28, 2011.
-
Doctors' Conflicting Interests Can Cost Money and Lives,
and Hinder Medical Discoveries: Are Doctors' Industry
Ties Influencing Your Care? Opinion by Stefan
Kruszewski, ABC News, March 28, 2011.
-
When Government Propaganda Masquerades as Science,
by Robert Whitaker, Psychology Today, March 25,
2011.
-
Department of Justice Moves to Protect Medicaid
Defrauders: Court Sets Hearing for April 7th, Law
Project for Psychiatric Rights, March 24, 2011.
-
J&J’s Risperdal Letter Violated Consumer Law, Jury
Finds, by Jef Feeley and Gary Henderson,
Bloomberg News, March 22, 2011.
-
J&J
Duped South Carolina Doctors Over Risperdal, Lawyer Says,
by Jef Feeley and Gary Henderson,
Bloomberg News, March 21, 2011.
-
AstraZeneca Pays States $68M for Seroquel Probe,
Pharmalot, March 10, 2011.
-
Medical journals still publishing studies that fail to
reveal funding: study, by Carly Weeks, The Globe
and Mail, March 9, 2011.
-
A
Sugared Pill, by Andrew Jack, Financial Times,
March 8, 2011.
-
Reviews of Drug Trials underreport Conflicts of Interest,
by Winston Chung, Child Psychiatrist, San Francisco
Chronicle, March 8, 2011.
-
The
Make-Believe Billion: How drug companies exaggerate
research costs to justify absurd profits, by Timothy
Noah, Slate, March 3, 2011.
-
I'm
Bipoloar, You're Bipolar: Your mental illness is their
financial gain, by Mikkel Borch-Jacobsen, Adbusters, March 2, 2011.
-
Physicians: Prescribing Less May Improve Outcomes,
Excessive Pills, Overtreatment, May Do More Harm Than
Good, Opinion by Stefan P. Kruszewski, M.D., ABC
News, February 23, 2011.
-
Concern over high medication rate among foster kids:
Review of kids’ psych drugs urged, by April Hunt, The Atlanta Journal-Constitution, February 23, 2011.
-
For Some Troops, Powerful Drug Cocktails Have Deadly
Results, reported by James Dao, Benedict Carey and
Dan Frosch and written by James Dao, The New York
Times, February 12, 2011.
-
Short
time on antipsychotics may up heart disease, by Leigh Krietsch Boerner,
Reuters Health, February 9, 2011.
-
FDA panel advises more testing of 'shock-therapy'
devices, by David Brown, Washington Post,
January 28, 2011.
- Health Advocacy Groups Take
Drug Company Cash—Often Without Full Disclosures, Report Says, by Marian
Wang, ProPublica, January 13, 2011
- PsychRights' January 24, 2011, Letter to the FDA
regarding reclassification of Electroshock machines.
-
The Reflexive Call for Fewer Liberties, by Glenn
Greenwald, Salon.com, January 12, 2011.
-
Crazy Talk,
by Vaughan Bell, Slate, January 9, 2011.
-
Military Kids Taking More Psychiatric Drugs, by
Karen Jowers and Andrew Tilghman, Army Times,
January 2, 2011.
-
Researcher Finds Evidence Lacking For Widespread Use Of
Costly Antipsychotic Drugs, Medical News Today,
January 7, 2011.
- Judge blocks discovery into aspiring lawyers' mental
health, by Leigh Jones, The National Law Journal,
January 4, 2011.
-
Psychiatrist tries a different approach with dementia
patients, by Barbara Peters Smith, The Herald
Tribune, January 2, 2011.
-
So
Young and So Many Pills: More than 25% of Kids and Teens
in the U.S. Take Prescriptions on a Regular Basis,
by Anna Wilde Mathews, The Wall Street
Journal, December 28, 2011.
-
Inside the Battle to Define Mental Illness, by Gary
Greenberg, Wired Magazine, December 27, 2011.
-
Med Schools Flunk at Keeping Faculty Off Pharma Speaking
Circuit, by Tracy Weber and Charles Orsntein, Pro
Publica, December 19, 2010.
-
Rapidly Increasing Criminal and Civil Monetary Penalties
Against the Pharmaceutical Industry: 1991 to 2010,
by Sammy Almashat, M.D., M.P.H, Charles Preston, M.D.,
M.P.H, Timothy Waterman, B.S., Sidney Wolfe, M.D., Public Citizen’s Health Research Group, December 16,
2010.
-
Prescription Drugs Associated with Reports of Violence
Towards Others, by Thomas J. Moore, Joseph
Glenmullen, and Curt D. Furberg, PLoS One Vol 5:
12 (December 2010).
-
The Great DNA Data Deficit: Are Genes for Disease a
Mirage? by Jonathan Latham and Allison Wilson, The Pioscience Resource Project, December 8, 2010.
-
Risks of ECT outweigh benefits, review finds, by
Carl Obrien, The Irish Times, December 7, 2010.
-
The effectiveness of electroconvulsive therapy:: A
literature review, by John Read and Richard Bentall, epidemiologia e Psichiatria Sociale, 19: 4 (2010).
-
Some doctors handing out prescriptions to kids for
potent medications, by Darren Barbee, Star
Telegram (Texas), December 11, 2010.Drug Maker Wrote Book Under 2 Doctors’ Names, Documents
Say, by Duff Wilson, The New York Times,
November 29, 2010.
- Psychiatric researcher pleads guilty to research fraud,
by David Gutierrez, Natural News, November 29,
2010.
-
The
Problem of Insufficient Reporting and Publication Bias:
Published literature tends to overestimate benefits and
underestimate harms, by Patricia F. Dimond, PhD.,
Genetic Engineering & Biotechnology News, November 22,
2010.
-
Letter to U.S. Senator Carper on Pediatric
Psychopharmacology Medicaid Fraud, November 9, 2010.
-
Ex-Glaxo Executive Is Charged in Drug Fraud, by Duff
Wilson, The New York Times, November 9, 2010.
- Lies, Damned Lies, and Medical Science, by David H.
Freedman, the Atlantic, November, 2010.
-
Firm with Earth City unit [Forest Labs] is settling
suits over drugs tied to suicides, by Jim Doyle, St. Louis Today, October 30, 2010.
-
First-Time Antipsychotic Use Linked to Rapid Weight
Gain, Adverse Metabolic Changes in Kids, by Caroline
Cassels, Medscape Medical News, October 29, 2010.
-
Psychiatrists Dominate "Doctor-Dollars" Database Listing
Big Pharma Payments, by Shelley Wood and Robert
Lowes, Medscape Medical News, October 22, 2010.
-
Training Lecture on Psychiatric Drugs: the important association between
psychiatric drugs, medical illness, and premature death.
-
Another
Volley in Rx Probe, by Mar Cabra and John Dorschner,
The Miami Herald, October 21, 2010.
-
Letter from Sen. Charles Grassley to Secretary of Health
& Human Services Sebelius regarding prolific Medicaid
prescribers, October 20, 2010.
-
Prescription for prestige: Drug firms’ speaking fees
flow to Harvard doctors; concerns about influence prompt
new restrictions, by Liz Kowalczyk, Boston Globe,
October 19, 2010.
-
Are we medicating a disorder or treating boyhood as a
disease? By Carolyn Abraham, The Globe and Mail,
October 18, 2010.
-
Doctors ignored drugs warnings, by Janice Barker,
Oldham Chronicle, October 18,2010.
-
J&J Must Pay $257.7 Million Over Risperdal Marketing,
by Jef Feeley and Margaret Cronin Fisk, Bloomberg,
October 14, 2010.
-
Why
genes are leftwing; The right loves genetic explanations
for poverty or mental illness. But science fingers
society, by Oliver James, The Guardian,
October 12, 2010.
-
Side Effects May Include Lawsuits, by Duff Wilson,
The New York Times, October 2, 2010.
-
Psych Meds in Jail,
Youth Today, October 1,
2010.
-
Novartis Pharmaceuticals Corporation to Pay $422.5
Million for off-label Drug Marketing: Company reaches
plea and civil settlement agreements, United States
Attorney, Eastern District of Pennsylvania, September
30, 2010.
-
Government orders action on 'chemical cosh' which kills
thousands, London Telegraph, September 25,
2010.
-
ADHD: A Global Epidemic or Just a Bunch of Fidgety Kids?
by John Cloud, Time Magazine, September 22, 2010.
-
Forest, Maker of Celexa, to Pay More Than $313 Million
to Settle Marketing Case, by Natasha Singer, The
New York Times, September 15, 2010.
-
Adverse
drug reactions from psychotropic medicines in the
paediatric population: analysis of reports to the Danish
Medicines Agency over a decade, by Use Aagaard and
Ebba H Hansen, BMC Research Notes (2010).
-
Symposium
on DSM 5, Part II, Association for the
Advancement of Philosophy and Psychiatry, Vol 17,
No. 2 (2010).
-
Child’s
Ordeal Shows Risks of Psychosis Drugs for Young, by
Duff Wilson, The New York Times, September 1,
2010.
-
The
STAR*D Scandal: A New Paper Sums It All Up, by
Robert Whitaker, Psychology Today, August 27,
2010.
-
Making a Killing: Clinical Trials Have Become Marketing
Exercises for Big Pharma-and cash-strapped universites
are helping make the sale. Too bad for Dan
Markingson, by Carl Elliot, Mother Jones,
September/October 2010.
-
Pharmaceuticals: A Market for Producing 'Lemons' and
Serious Harm, Analysis Finds, Sciene Daily,
August 17, 2010.
-
Letter to Senators Kerry and Lugar supporting the
ratifiction of the United Nations Convention on the
Rights of Persons with Disabilities (CRPD), August
16, 2010.
-
Zyprexa Document Leaker Loses His Appeal, by Ed
Silverman, Pharmalot, August 13, 2010
- Charlie Rose and the Mentally Ill, by Robert
Whitaker, Psychology Today, August 13, 2010.
-
FDA Drug
Safety Communication: Aseptic meningitis associated with
use of Lamictal (lamotrigine), August 12, 2010.
-
Illinois Medicaid Fraud Case
Using PsychRights' Model Complaint Unsealed, August 11, 2010
-
Some Pharmaceutical Clinical Trial Results Are Buried, Study Shows: Results
remain unpublished, hard to find, by Sharon Begley, Newsweek,
August 5, 2010.
- Why
antidepressants are simply a confidence trick: A leading psychologist claims
taking sugar pills would work just as well, by Prof. Irving Kirsch, The Daily Mail, August 3, 2010.
- Studies Halted at Brain Lab Over Impure Injections,
by Benedict Carey, The New York Times, by
Benedict Carey, July 16,2010.
-
Youth Lock-ups
Blasted, by Diana Zlomislic, Toronto Star, July 7, 2010.
- Sara Carlin, Paxil And Drug Safety In Canada, by Ed
Silverman, Pharmalot, June 30,2010.
-
Doc Goes To Jail In Pfizer Research Fraud Case, by
Ed Silverman, Pharmalot, June 25, 2010.
-
Psychiatric drugs fuel flood of diagnoses, by Dr.
Charles Barta, Green Valley News, June 19, 2010.
-
Psychotropic Drug Abuse in Foster Care Costs Government
Billions, by David Sessions, Politics Daily,
June 16, 2010.
-
Tracking the
American Epidemic of Mental Illness - Part III, by Evelyn Pringle,
OpEdNews, June 7, 2010.
- Antipsychotic
deflates the brain: Drug for schizophrenia causes side effects by
shrinking part of the brain, byAmy Maxmen, Nature News, June
6, 2010.
- Psychiatric Fads and Overdiagnosis, by Allen Frances, MD,
Psychology Today, June 2, 2010.
- Tracking the
American Epidemic of Mental Illness - Part II, by Evelyn Pringle, OpEdNews, June 2, 2010.
- Medicating
Children: A “Whistleblower’s” Lawsuit Raises a Novel Legal Question, by
Robert Whitaker,
Mad in America blog, Psychology Today, June 2, 2010
- Tracking the
American Epidemic of Mental Illness - Part I, by Evelyn Pringle, OpEdNews, June 1, 2010.
- Curbing Drug-Company
Abuses: Are Fines Enough? By Ken Stier, Time Magazine, May 30,
2010.
- Summing Up the NIMH
Trials: Evidence of an Effective Paradigm of Care? By Robert Whitaker,
Mad in America blog, Psychology Today, May 28, 2010.
- Let's Call the Whole
Thing Off, by By Irwin Feinberg, MD, Psychiatric Times, May 27,
2010.
- Yet Another Disappointment:
First CATIE, and Now the 12-Month Results from TEOSS, by Robert
Whitaker, Mad in America blog, Psychology Today, May 25, 2010.
- Psychiatric Drugs and Poor Kids, by Bruce E. Levine,
The Huffington
Post, May 20, 2010.
- Foster Children Mistreated, Suit Against City Claims, by A.G.
Sulzberger, The New York Times, May 12, 2010.
- The DSM5
Field Trial Proposal—An Expensive Waste of Time, by Allen Frances, MD,
Psychiatric Times, May 7, 2010
- State of
Utah Complaint Against Manufacturers of Risperdal and Seroquel, May 3,
2010.
-
So much bluster, but foster kids' drug nightmare continues, by Fred
Grimm, The Miami Herald, May 1, 2010.
-
Mental
Health Group’s State Chapters Get Millions From Pharma, by Katherine
Hobson, The New York Times, April 28, 2010.
- AstraZeneca Pays $520
Million to Settle Seroquel Whisteleblower Claims, April 28, 2010.
- "Anatomy of an
Epidemic: The hidden damage of psychiatric drugs, by Jed Lipinski, Salon.com, April 27, 2010.
- For $520
Million, AstraZeneca Will Settle Case Over Marketing of a Drug, by Duff
Wilson, The New York Times, April 26, 2010.
- Sen. Grassley Letter to the
National Alliance for Mental Illness (NAMI), April 26, 2010.
- Pfizer’s Geodon
Trial Had ‘Significant Violations,’ by Catherine Larkin, Bloomberg
News, April 20, 2010.
- A
Psychiatric Revolution, by Andrew Scull, The Lancet, April 10,
2010.
- Red flags
overlooked in 12-year-old's prescription drug death, by Carol Marbin
Miller, The Miami Herald, April 19, 2010.
- Ethical and
Moral Obligations Arising From Revelations of
Pharmaceutical Company Dissembling, by James B.
Gottstein, JD, Ethical Human
Psychology and Psychiatry, Vol. 12, No. 1:22-29
(2010)
-
Popular anticonvulsant drugs raise suicide risks, by
Julie Steenhuysen, Reuters, April 13 2010
- Feds
Found Pfizer Too Big To Nail, by Drew Griffin and
Andy Segal, CNN, April 2, 2010.
-
The Peer Review "Fig Leaf": Vera Hassner Sharav, by
Suzan Mazur, Scoop Independent News, April 1,
2010.
-
COMMENTARY: Wholesale sedation of young children
medically, morally indefensible, by Larry Diller, The Patriot Ledger, March 27, 2010.
-
Civil Minutes Order Denying Motion to Dismiss by Sandoz
and Eli Lilly on the grounds that the FDA would not
have allowed a warning concerning Prozac’s suicide risks
and that a generic manufacturer is not allowed to
voluntarily revise its warning label, in Dorsett v.
Sandoz, Inc., et al., Case No. CV 06-7821, (C.D.Cal.,
March 26, 2010).
-
Psychiatrists And Pharma: Undue Influence?
Pharmalot, March 25, 2010.
-
Top Scientist Calls for Ethics Cleanup Around "Big
Pharma," USA Today, March 23, 2010.
-
Medicating the military: Use of psychiatric drugs has
spiked; concerns surface about suicide, other dangers,
by Andrew Tilghman and Brendan McGarry, Army Times,
March 17, 2010.
-
FDA Warns
Psychiatrist Who Treated Dead Foster Child, by Carol
Marbin Miller, The Miami Herald, March 16, 2010.
-
Pregnant women warned over Prozac risk to foetus,
The London Times, March 12, 2010.
-
J&J Pushed Risperdal for Elderly After U.S. Warning,
Files Show, by Margaret Cronin Fisk, Jef
Feeley and David Voreacos, Bloomberg, March 10,
2010.
-
Nursing home drug use puts many at risk Antipsychotics
given to some with dementia, by Kay Lazar, Boston
Globe, March 8, 2010
-
Does the DSM-IV Clinical Significance Criterion for
Major Depression Reduce False Positives? Evidence From
the National Comorbidity Survey Replication, by
Jerome C. Wakefiield, Ph.D., D.S.W., Mark F. Schmitz,
Ph.D., and Judith C. Baer, Ph.D., American Journal of
Psychiatry, 167:298-304 (2010).
-
Cold Case Files - Paxil Birth Defects, by Evelyn
Pringle, Scoop, March 2, 2010
-
New York Is Ordered to Move Mentally Ill Out of Group
Homes, by A.G. Sulzberger, The New York Times,
March 1, 2010.
- US Seeks More Information About J&J Antipsychotic
Marketing, by By Peter Loftus, The Wall Street
Journal, March 1, 2010.
-
It's not too late to save 'normal':Psychiatry's latest
DSM goes too far in creating new mental disorders,
by Allen Frances, Los Angeles Times (opinion),
March 1, 2010.
-
Psychiatry's Main Method to Prevent Mistaken Diagnoses
of Depression Doesn't Work: Study, Science Daily
, February 25, 2010.
-
AstraZeneca Tied Studies to Marketing, Witness Says,
by Jef Feeley and Margaret Cronin Fisk, Business Week,
February 23, 20101.
-
Mother
Guilty of Murder--Pediatric Bipolar Disorder Innocent, by By Lawrence
Diller, M.D., Psychology Today, February 20, 2010.
- Senator Grassley
letter to WebMD regarding it conducting the depression screening test
developed by Eli Lilly and other ties to industry, February 18, 2010.
- Paxil Birth
Defect Litigation - First Trial A Bust for Glaxo, by Evelyn Pringle, Natural News, February 17, 2010.
- Revising
Book on Disorders of the Mind, by Benedict Carey, The New York Times, February 10, 2010.
-
Lawyer takes on
psychiatric industry for over-prescribing foster children, by Rhonda
McBride, KTUU, February 11, 2010.
- Alaska psychiatrists accused of wrongly medicating
children: FRAUD CLAIM: Doctors followed drug marketing
recklessly, suit says, by Megan Holland, Anchorage Daily News, February 11, 2010.
-
Revising
Book on Disorders of the Mind, by Benedict Carey, The New York Times, February 10, 2010.
-
Suing Doctors Who Use Drugs as Chemical Straitjackets
for Children, Alison Bass Blog, February 8,
2010.
-
AstraZeneca
Facing 26,000 Lawsuits Over Seroquel, by Jeff Feeley and Margaret Cronin
Fisk, Bloomberg News, February 3, 2010.
- AstraZeneca "Suppressed" Drug Test Data,
BBC News,
January 26, 2010
-
Fattened by Pills: One of the Biggest Causes of Obesity
is Seldom Discussed, by Paula J. Caplan, Boston
Globe, January 24, 2010.
-
Letter
from Senator Charles Grassley to the National Institutes
of Health, January 20, 2010.
-
Johnson & Johnson Accused of Drug Kickbacks, by
Natasha Singer, The New York Times, January 16,
2010.
- Doctor
Wrote 1,000 Scripts/Week, by Carol Gentry, Health
News Florida, January 15, 2010.
-
Deal Made to
Monitor Brooklyn Hospital, by Anemonia Hartocollis, The New York
Times, January 8, 2010.
- Drugs May Aid Only Severe Depression, by Benedict
Carey, The New York Times, January 6, 2010.
-
More U.S. Patients Receive Multiple Psychotropic
Medications, Science Daily, January 5, 2010.
-
More Toddlers, Young Children Given Antipsychotics: Researchers Question the
"worrisome" Trend, by Jennifer Thomas, Health Day, January 4,
2010.
- Feds investigating high prescribing Fla. docs, by
Kelli Kennedy, Associated Press Writer, St.
Petersburg Times, December 17, 2009.
-
Anti-depressants 'up stroke risk,'
BBC,
December 15, 2009.
-
US Kids
Represent Psychiatric Drug Goldmine, by Evelyn
Pringle, Truthout, December 12, 2009.
-
Poor Children Likelier to Get Antipsychotics, by
Duff Wilson, The New York Times, December 12,
2009.
-
Psychiatry's Civil War,
New Scientist,
December11, 2009.
- UIC study alleges an overuse of drugs on juveniles at
understaffed Streamwood psychiatric hospital: UIC study
says understaffed site overmedicated kids, by David
Jackson, Chicago Tribune, December 11, 2009.
-
Letter from Sen. Charles Grassley to Laurie Flynn,
Executive Director, TeenScreen National Center for
Mental Health Checkups at Columbia University, December
7, 2009, regarding pharmaceutical company funding.
-
Antipsychotics, Diabetes & Kids,
The Wall Street
Journal, December 4, 2009.
-
Information for Healthcare Professionals: Risk of Neural
Tube Birth Defects following prenatal exposure to
Valproate, December 3, 2009.
-
AstraZeneca Judge to Urge Return of Seroquel Cases to
Courts, by Jef Feeley and Margaret Cronin Fisk, Bloomberg News, November 19,2009.
-
Doctor-drugmaker ties: Psychiatrist Dr. Michael
Reinstein received nearly $500,000 from antipsychotic
drug's manufacturer: Company paid him to promote
Seroquel despite misgivings about his research, by
Christina Jewett and Sam Roe, Chicago Tribune,
November 11, 2009.
-
Doctor gives risky drugs at high rate: Complaints, suits
follow psychiatrist to thousands with serious mental
illness, by Christina Jewett and Sam Roe, Chicago
Tribune, November 10, 2009
-
Pfizer Broke
the Law by Promoting Drugs for Unapproved Uses, by
David Evans, Bloomberg News, November 9, 2009.
-
AstraZeneca Pays Millions to Settle Seroquel Cases,
by Duff Wilson, The New York Times, October 30,
2009.
- Weight Gain
Associated with Antipsychotic Drugs, by Duff Wilson,
The New York Times, October 28, 2009.
-
The
Loss of Client Agency into the
Psychopharmaceutical-Industrial Complex, by Thomas
L. Murray, Jr., Journal of Mental Health Counseling,
Vol. 31, No. 4: 283-308 (2009).
-
Compromised Care: Psychotropic drugs given to nursing
home patients without cause: Many Illinois residents get
medications they don't need or want. The result? A
threat to the lives of our elderly, by Sam Roe, Chicago Tribune, October 27, 2009.
-
Drug Makers Are Advocacy Group’s Biggest Donors, by
Gardiner Harris, The New York Times, October 22,
2009.
- F.D.A. Lags in Banning Researchers After Fraud, by
Gardiner Harris, The New York Times, October 22,
2009.
- Lawsuit Hits Credibility of Pfizer Drug and Research,
The (Connecticut) Day, October 4, 2009.
-
Bad Medicine
(Editorial), St. Petersburg Times, September 21,
2009.
-
Opportunity to Object to FDA On Safety of Electroshock
Machines
-
Glaxo
Executive’s Memo Suggested Burying Drug Studies, by
Jef Feely and Margaret Cronin Fisk, Bloomberg News,
September 15, 2009.
-
JAMA, Free Speech,
and Conflicts of Interest, by Jonathan Leo, Society, 10.1007/s12115-009-9259-9 (2009).
-
Lilly Paid
Doctors to Prescribe Zyprexa, Notes Show, by
Margaret Cronin Fisk and Jef Feeley, Bloomberg News,
September 8, 2009.
-
Federal Court Decision ruling that New York's larger
Adult Homes violate the Americans with Disabilities Act
(ADA), September 8, 2009.
-
Ghostwriting: The Dirty Little Secret of Medical
Publishing That Just Got Bigger; Editorial from the
PLoS Medicine Editors, September 2009 | Volume 6 | Issue
9 | e1000156.
-
Justice Department Announces Largest Health Care Fraud
Settlement in Its History: Pfizer to Pay $2.3 Billion
for Fraudulent Marketing, Department of Justice,
September 2, 2009.
-
Third Amended Complaint.
-
Government Intervention with Settlement Agreement
-
AIG of Drugmakers Pfizer Is Too Big to Be Guilty, by Ann Woolner,
Bloomberg News, September 4, 2009.
- A Drug Maker's
Playbook Reveals a Marketing Strategy, by Gardiner Harris, The New York Times, September 2, 2009.
-
Lexapro Fiscal 2004 Marketing Plan,
sent to Sen. Kohl by Sen. Grassley, August 12, 2009.
- A
Drug Maker's Playbook Reveals a Marketing Strategy,
by Gardiner Harris, The New York Times, September
2, 2009.
-
Disparities: Study
Finds Risk in Off-Label Prescribing, The New York Times, August
25, 2009.
-
Glaxo Used Ghostwriting to
Promote Paxil: Offered to help doctors publish articles on drug, by Matthew Perrone, Associated Press/Boston Globe, August 20, 2009.
-
Doped and Duped: Adverse
effects of widely-prescribed drugs are often overlooked because there is so
little truly independent academic evidence, by David Healy, Guardian
(UK), August 8, 2009.
- Cheryl Stevens Letter to Oprah Winfrey, August 6, 2009.
-
Drug Firms' Medical Staffs
Say What Salespeople Can't, by Shirley S. Wang, The Wall Street
Journal, June 26, 2009.
-
Kids
need care, not pills, ex-foster children tell panel, by Amy Sherman, Miami Herald, June 19, 2009.
-
Kings County
Hospital doctors, nurses facing charges in Esmin Green death-by-neglect case,
by John Marzulli, New York Daily News, June 19, 2009.
-
Lilly Sold Drug for Dementia Knowing It Didn’t Help, Files Show, by
Margaret Cronin Fisk, Elizabeth Lopatto and Jef Feeley, Bloomberg
News, June 12, 2009.
-
Eli Lilly
‘Ghostwrote’ Articles to Market Zyprexa, Files Show, by Elizabeth
Lopatto, Jef Feeley and Margaret Cronin Fisk, Bloomberg News, June
12, 2009.
- FDA Throws
Lifeline to Antipsychotic Pushers, by Evelyn Pringle, Counter Punch,
June 12, 2009.
- Drug rules to
protect kids were ignored, DCF says, by Carol Marbin Miller, The
Miami Herald, June 9, 2009.
- When Drug
Trials Go Terribly Wrong: Lessons from a Bereaved Mother, Psychology
Today Blog, June 8, 2009.
- Foster Care
Failures, St. Petersburg Times Editorial, June 7, 2009.
- Lawsuit links psychiatric drugs to Tamarac child's death,
by Carol Marbin Miller, The Miami Herald, June 4,
2009.
-
Conflicts of
interest bedevil psychiatric drug research, USA
Today, June 3, 3009.
-
Drug Agency May Reveal More Data on Actions, by
Gardiner Harris, The New York Times, June 2,
2009.
-
DCF's
drug records suspect, by Kris Hundley and Connie
Humburg, Tampa Bay Times, May 29, 2009.
-
AstraZeneca Is Accused Over Seroquel, by Jonathan D.
Rockoff, The Wall Street Journal, May 20, 2009.
-
Children's
Use Of Psychiatric Drugs Begins To Decelerate, by
David Armstrong, Wall Street Journal, May 18,
2009.
-
Dr. Grace E. Jackson Affidavit on John R. Weisz
and Peter S. Jensen, "Efficacy and Effectiveness of
Child and Adolescent Psychotherapy and Pharmacotherapy,"
Mental Health Services Research 1:3 (1999): 125-157.
-
Depraved Indifference: Drunk Driving on the Therapeutic
Highway, by Richard Warner, May 14, 2009.
-
Drug Limits
Skirted for Foster Kids, by Carol Marbin Miller, The Miami Herald,
May 8, 2009.
- Massive Medicaid Fraud
Exposed: PsychRights Calls on Members of Congress for Assistance, May 5,
2009.
- Broward
child's suicide raises questions about medication,
by Carol Marbin Miller, The Miami Herald, April
21, 2009.
- Re: Seroquel
for Adjunctive Therapy in Major Depressive Disorder,
by Dr. Stefan Kruszewski, April 14, 2009, in response to
the FDA advisory committee recommending the FDA approve
Seroquel for such use.
-
Atypical
antipsychotics: too hard a sell? by Melissa Healy,
Los Angeles Times, April 13, 2009
-
Grassley
Probes Financing of Advocacy Group for Mental Health,
by Nicole Gaouette, Bloomberg News, April 6,
2009.
- To Move More
Prescription Drugs, Sales Reps Sling Swag, by Kris
Hundley, St. Petersburg Times, April 5, 2009.
-
Conflicts for FDA Committee Set to Weigh Risks of
Seroquel, by Miriam Hill, Philidelphia Enquirer,
April 4, 2009.
-
Most Psychiatrists Who Wrote Clinical Guidelines Had
Financial Ties to Drug Companies, Study Shows, Kaiser Daily Health Policy Report, April 3, 2009.
-
Richard
Warner's review of Doctors of Deception, Linda Andre's book about
electroshock, April, 2009.
-
AMA Requests Probe of JAMA Charges,
Wall Street Journal, March
28, 2009.
-
3 Researchers at
Harvard are Named in Subpoena, by Gardiner Harris, New York Times,
March 28, 2009.
-
Approval process
lowers the number of kids on atypical prescriptions, by Kris Hundley, St. Petersburg Times,
March 27, 2009.
- Powerful Proponent of Psychiatric Drugs for Children Primed for a Fall,
by Lawrence Diller, San Francisco Gate, March 27, 2009.
-
Debate Over Drugs For ADHD
Reignites: Long-Term Benefit For Children at Issue, by Shankar Vedantam,
Washington Post, March 27, 2009; A01.
-
Psychiatric Group Ends
Industry-Sponsored Seminars, by Benedict Carey, New York Times,
March 26, 2009.
-
Kids with ADHD May
Learn Better by Fidgeting, by John Cloud, Time Magazine, March
25, 2009.
- Drug Maker Told Studies Would Aid It, Papers Say, by Gardiner Harris,
New York Times, March 20, 2009.
-
U doctor scrutinized
over drug research: Questions raised after positive review of drug conflicts
with maker's, by Jeremy Olson Twin Cities Pioneer Press, March
19, 2009.
-
A Silenced Drug Study
Creates An Uproar, by Shankar Vedantam, Washington Post,
March 18, 2009.
-
Memo to FDA Staff:
Don't Leak This, Wall Street Journal, March 17, 2009.
-
Seroquel user wants
judge to unseal papers for FDA, by Linda A. Johnson, Associated Press,
March 11, 2009.
-
J&J Unit Marketed
Risperdal Off-Label, Ex-Workers Say (Update2), Bloomberg News,
March 6, 2009.
- United States Supreme Court March 4, 2009,
slip opinion in Wyeth v. Levine, holding state product liability lawsuits over drugs
are not pre-empted because the Food and Drug Administration (FDA) has
approved the label.
- Prosecutors Plan Crackdown on Doctors Who Accept Kickbacks, by
Gardiner Harris, New York Times, March 4, 2009.
- Eli Lilly
and the Case for a Corporate Death Penalty, by Bruce
E. Levine, AlterNet, March 3, 2009.
-
Exclusive: Sen. Hatch's Secret Drug Firm Links,
The Washington Times, March 2, 2009.
-
Drug
Maker’s E-Mail Released in Seroquel Lawsuit, by Duff
Wilson, New York Times, February 28, 2009.
-
AstraZeneca
Papers Raise Seroquel Issues, by Shirley S. Wang and
Avery Johnson, The Wall Street Journal, February
27, 2009.
-
Drug
Firm Unseals Papers, by Kris Hundley, Tampa Bay Times,
February 27, 2009.
- U.S. Probes Emory
Doctor's Glaxo Ties, by David Armstrong, Wall
Street Journal, February 26, 2009.
- United States Files Complaint Against Forest
Laboratories for Allegedly Violating the False Claims
Act: Pharmaceutical Company Allegedly Marketed Drugs for
Unapproved Pediatric Use and Paid Kickbacks, United
States Department of Justice, February 25, 2009.
-
Drugmaker Wants to Seal Info -- For you, by Kris
Hundley, Tampa Bay Times, February 14, 2009.
-
Army Suicides -- Plus ca change, c'est la meme chose,
by Grace Jackson, February 10, 2009.
-
Abuse is
Found at Psychiatric Unit Run by the City, New
York Times, February 6, 2009.
- NIDA Study Shows That
Methylphenidate (Ritalin) Causes Neuronal Changes in Brain
Reward Areas: Similarities and Differences Compared to Cocaine were Found,
National Institute of Health (NIH), February 2, 2009.
- Good for Business, Bad
for Patients? Pfizer's Plan to Buy Rival Wyeth Could Mean ad News for
Patients, Physician Says, Opinion by John Abramson, MD, ABC News,
January 30, 2009.
- Child Shock Therapy,
Australian Herald Sun, January 25, 2009.
- Bitter Pill:
Created to treat schizophrenia, Zyprexa wound up being used on misbehaving
kids. How the pharmaceutical industry turned a flawed and dangerous drug
into a $16 billion bonanza, Rolling Stone, by Ben Wallace-Wells,
January 23, 2009.
- Crimes and
Confidentiality, by David Egilman, The Pump Handle, January 22,
2009.
- Study Finds Drug Risks
with Newer Antipsychotics, by Benedict Carey and Roni Caryn Rabin, New York Times, January 15, 2008.
- Eli
Lilly and Company Agrees to Pay $1.415 Billion to
Resolve Allegations of Off-label Promotion of Zyprexa
$515 Million Criminal Fine Is Largest Individual
Corporate Criminal Fine in History; Civil Settlement up
to $800 Million, U.S. Department of Justice,
January 15, 2009.
- Lilly Said to Be
Near $1.4 Billion U.S. Settlement on Drug, by Gardiner Harris, New
York Times, January 15, 2009.
- ADHD Medication: Can Your Child Go Without? Behavioral
therapy for ADHD—and parent retraining, too—can be good
alternatives to medication, by Nancy Shute, U. S.
News & World Report, January 14, 2009
-
Report of the
Office of Inspector General on The Food and Drug Administration's Oversight
of Clinical Investigators' Financial Information (January 2009).
- SSRI Pushers Under Fire, by Evelyn
Pringle, The Scoop, January 2, 2009.
- Users and Survivors of
Psychiatry on the International Stage: A Snapshot, by Peter Lehman,
December, 2008.
- State Pharmacist
Convicted of Conflict of Interest, by Debra Erdley, Pittsburgh
Tribune-Review, December 24, 2008.
- FDA Requires
Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic
Medications, December 16, 2008.
- Get Kids Off
Medicine Program is Launched in Metro Area, Louisiana Weekly, December 15, 2008.
-
Antidepressants
may damage more sex lives, by Carey Goldberg, Boston Globe, December 15, 2008
-
4,000 Kids
Under 10 on Mood Drugs, The Australian,
December 3, 2008.
-
No Reason to Prefer Atypical Antipsychotics of Older
Drugs, by John Gever, Senior Editor, MedPage
Today, December 4, 2008.
-
Official
warnings issued: The ADHD drug Strattera CAUSES
psychosis, hallucinations, mania and agitation, by
Janne Larsson, TransworldNews, December 1, 2008.
-
Expert
or Shill, New York Times Editorial, November
30, 2008.
-
Psychiatric Drugs & Suicide: How Medical Agencies
Deceive Patients and Relatives, by Janne Larsson,
November, 2008.
-
Papers
Reveal Push on Drug Firm Funds: Prominent Doctor Tied to
Efforts, by Carey Goldberg, Boston Globe,
November 25, 2008.
-
Research Center Tied to Drug Company, by Gardiner
Harris, New York Times, November 24, 2008.
- Ailing FDA May Need a
Major Overhaul, Officials and Groups Say, by Rob
Stein, Washington Post, November 26, 2008.
-
Psychiatric
Care's Peril and Profits: Lapses at Psychiatric
Solutions Inc., a major hospital chain with high
earnings, have put patients at risk, regulators find.
Some have even died, by Christina Jewett and Robin
Fields, Los Angeles Times, November 23, 2008.
-
Popular Radio Host Has Drug Company Ties, by
Gardiner Harris, New York Times, November 22,
2008.
-
Use of Antipsychotics in Children is Criticized, by
Gardiner Harris, New York Times, November 19,
2008.
-
Foster kids say medication is overprescribed;
Legislative Meeting: Youths and graduates of the system
offer alternatives, by Lisa Demer, Anchorage
Daily News, November 15, 2008.
-
The Wholesale Sedation of America's Youth, by Andrew
M. Weiss, Skeptical Inquirer, December, 2008, Vol
32:31-36.
-
Congressional
Report: FDA Career Staff Objected to Agency Preemption Policies,
October,2008.
-
State
medication protocol researchers sought money from drug firms, by Emily
Ramshaw, The Dallas Morning News.
- Drugs
and Disclosure, New York Times Editorial, October 10, 2008.
- Suit Alleges
Pfizer Spun Unfavorable Drug Studies, by Keith Winstein, Wall Street
Journal, October 8, 2008.
-
Ignored: the mentally
ill killed by drugs that are meant to help them: Campaigners plan to use World
Mental Health Day to highlight discrimination within the medical profession
against some of its most vulnerable patients, by Nina Lakhani, UK
Independent, October 5, 2008
- Top
Psychiatrist Didn’t Report Drug Makers’ Pay, by Gardiner Harris, New York
Times, October 4, 2008
- Doctors
told to curb use of Ritalin in hyperactive children
Ritalin pills, by Mark Henderson, Science Editor, UK Times, September 24, 2008.
-
Senator questions doctors' ties to drug companies,
by Emily Ramshaw, The Dallas Morning News,
September 24, 2008.
-
A Conversation With Nancy C. Andreasen: Using Imaging to
Look at Changes in the Brain, by Claudia Dreifus,
New York Times, September 16, 2008
-
Risks
Found for Youths in New Antipsychotics, by Benedict
Carey, New York Times, September 15, 2008
-
Judge to
Unseal Documents on the Eli Lilly Drug Zyprexa, by
Mary Williams Walsh, New York Times, September 6,
2008.
-
Conflict of interest fears halt children's mental health
project, August 18, 2008, by Emily Ramshaw, The
Dallas Morning News.
-
The
incidence and prevalence of diabetes in patients with
serious mental illness in North West Wales: Two cohorts,
1875–1924 & 1994–2006 compared, by Joanna Le Noury,
Afshan Khan, Margaret Harris, Winnie Wong, Dawn
Williams, Tony Roberts, Richard Tranter and David Healy,
BioMed Central, August 7, 2008.
-
Editorial:
The Age of Conflicts—of Interest, by Ronald Pies,
MD,Psychiatric Times. Vol. 25 No. 9, August 1, 2008.
- Suicides
& Psychiatric Drugs: A report based on data from The
National Board of Health and Welfare in Sweden, by
Janne Larsson
-
To See or
Not to See "Schizophrenia" and the Possibility of Full
"Recovery," by John Breeding, Ph.D., Journal of
Humanistic Psychology, 2008
-
Are Our Leading
Pediatricians Drug Industry Shills, by Lawrence
Diller, MD, SFGate, July 13, 2008
-
Psychiatric Group Faces Scrutiny Over Drug Industry Ties,
by Benedict Care and Gardiner Harriss, New York Times,
July 12, 2008.
-
Doctors Say Medication is Overused in Dementia,
New York Times, June 24, 2008.
- Key opinion leaders:
independent experts or drug representatives in disguise?
by Ray Moynihan, visiting editor, British Medical
Journal, June 21, 2008.
-
US
Investigation Into Glaxo And Paxil Widens, Pharmalot, by Ed Silverman, June 20, 2008.
-
Glaxo Attracts
Questions Over Data in Paxil Studies: Unsealed Report
Claims Suicide Risk Was Miscalculated, by By Alicia
Mundy and Jeanne Whalen, Wall Street Journal, June
14, 2008; Page A4.
-
Researchers Fail to Reveal Full Drug Pay, by
Gardiner Harris & Benedict Carey, New York Times,
June 8, 2008.
-
America's Medicated Army,
Time Magazine, June
5, 2008.
-
Medication
Effects and the Invisible Wounds of War - Why We Need A
Blue Ribbon Panel on Soldier Suicide and Iatrogenic
Harm, by Grace E. Jackson, Veterans for Common
Sense.
-
Irrational
Healers, by David Healy, MD, Psychotherapy and
Psychosomatics, 77:198-200 (2008)
-
Critics
say drug firms' payments to doctors are conflict of
interest: What they spend: A look at drug company
spending in Minnesota — on top specialties and select
psychiatrists, by Jeremy Olson and Paul Tosto,
Pioneer Press, May 20, 2008.
- Stealth
Marketers: Are doctors shilling for drug companies on
public radio? by Shannon Brownlee and Jeanne Lenzer,
Slate, May 9, 2008.
-
From the American
Psychiatric Association Annual Conference, May 9, 2008:
Drug Interactions
a Common Risk for Schizophrenic Patients.
-
To Hell and Back, by Thor Nystom,
The University
Daily Kansan, May, 2008.
-
Studying
Placebo Effects Advance the Neuropsychiatric
Understanding of Medical Interventions, by Stefan P.
Kruszewski, M.D., British Medical Journal, May 7,
2008.
- Eli Lilly's 1st
Quarter, 2008, Report on grants.
-
Re-focusing upstream: New Drugs, Poorly Recognised
Conditions, Genetic Polymorphisms and the Crisis in
Mental Health, by Yolande Lucire PhD MB BS DPM
FRANZCP (2008).
-
"Lethal Drugs Given for Dementia,
Times (UK)
Online, April 20, 2008.
-
Drug
Research: To Test or Tout? Robert Farley, St.
Petersburg Times, April 13, 2008.
-
One Drug, Two
Faces, New York Times, March 25, 2008.
- Lilly Faces Initial Zyprexa Trial: Alaska's Civil Suit
Might Set Pattern for Other Actions, by Avery
Johnson, Wall Street Journal, February 28, 2008.
-
Are Antidepressants Faith-Based Treatment? by
Bruce E. Levine, AlterNe, February 28, 2008.
-
Antidepressants: An Untold Story? by Jeanne Lenzer,
British Medical Journal, February 27, 2008.
-
NJ Legislator: Probe Antipsychotics, Kids & Medicaid,
by Ed Silverman, Pharmalot, February 25, 2008.
-
Drop
in SSRI Prescribing in the United Kingdom Did Not Lead
to Youth Suicide Spike, Medscape Medical News,
February 21, 2008.
-
State
(Montana) AG sues two drug companies, by Charles S.
Johnson, Helena Independent, State Bureau -
02/22/08
-
The Path
to Mental Health: Charles Barger Recovered From Illness
by Human Connection, by Kathleen Megan, Hartford
Courant, February 17, 2008.
-
Psychiatrists, Children and Drug Industry’s Role, by
Gardiner Harris, Benedict Carey and Janet Roberts, New York Times,
May 10, 2007.
-
Fox, Big Story w Doug Kennedy on NIU
shooter/antidepressants, February 15, 2008.
-
Unsealed (except 9 pages) Joseph Glenmullen, MD,
analysis of Paxil suicidality kept hidden by
GlaxoSmithKline.
-
Did
GSK trial data mask Paxil suicide risk? Science,
February, 2008.
-
Lilly in Talks With US, by Alex Berenson,
New
York Times, January 30, 2008 (Web Version).
- Lilly Considers $1 Billion Fine to Settle Case, by Alex Berenson,
New
York Times, January 31, 2008.
- No Significant
Association of 14 Candidate Genes With Schizophrenia in
a Large European Ancestry Sample: Implications for
Psychiatric Genetics, by Alan R. Sanders, M.D.,
Jubao Duan, Ph.D., Douglas F. Levinson, M.D., Jianxin
Shi, Ph.D., Deli He, B.S., Cuiping Hou, B.S., Gregory J.
Burrell, B.S., John P. Rice, Ph.D., Deborah A. Nertney,
B.S., Ann Olincy, M.D., Pablo Rozic, M.D., Sophia
Vinogradov, M.D., Nancy G. Buccola, A.P.R.N.B.C., Bryan
J. Mowry, M.D., Robert Freedman, M.D., Farooq Amin,
M.D., Donald W. Black, M.D., Jeremy M. Silverman, Ph.D.,
William F. Byerley, M.D., Raymond R. Crowe, M.D., C.
Robert Cloninger, M.D., Maria Martinez, Ph.D., and Pablo
V. Gejman, M.D., American Journal of Psychiatry,
AiA:1–10.
-
Selective Publication of Antidepressant Trials and Its
Influence on Apparent Efficacy, by Erick H. Turner,
M.D., Annette M. Matthews, M.D., Eftihia Linardatos,
B.S., Robert A. Tell, L.C.S.W., and Robert Rosenthal,
Ph.D, New England Journal of Medicine, 358;3
(January 2008). This study found that 37 of 38
trials that the F.D.A. viewed as having positive results
were published in journals, but only 14 of the 36
studies the FDA viewed as failed or unconvincing made it
into journals and 11 of those “conveyed a positive
outcome” that was not justified by the underlying F.D.A.
review.
-
The
ADHD drug Strattera – actions needed now, Open
Letter to the UK's Medicines and Healthcare products
Regulatory Agency (MHRA) by Jan Larsson.
- Forced Drugging of Children in Foster Care: Turning
Child Abuse Victims into Involuntary Psychiatric
Patients, by M. McKay, Ph.D., JOM, Vol. 22,
No. 2 (2007).
-
Rethinking
Social Recovery in Schizophrenia: What a Capabilities
Approach Might Offer, by Kim Hopper, Social
Science & Medicine 65 (2007) 868-879.
-
Some fear medicines may put foster kids' future health
at risk, by Gary Craig, Rochester Democrat and
Chronicle, December 10, 200.
- Drugs
for ADHD "Not the Answer," BBC, November 12,
2007.
- Danger drugs designed for schizophrenics used to calm
children, by Fiona MaCrae, Daily Mail,
September 11, 2007.
- Pediatric bipolar disorder: An object of study in the
creation of an illness, by David Healy and Joanna Le
Noury, International Journal of Risk & Safety in
Medicine, 19 (2007) 209–221.
- Senator Grassley seeks thorough review of nursing home
use of anti-psychotic drugs, December 6, 2007.
-
FDA Science and
Mission at Risk Report of the Subcommittee on Science
and Technology, prepared for the FDA by the FDA
Science Board, November 2007. This formerly
confidential report's three main conclusions are: (1)
The FDA cannot fulfill its mission because its
scientific base has eroded and its scientific
organizational structure is weak, (2) The FDA cannot
fulfill its mission because its scientific workforce
does not have sufficient capacity and capability, and
(3) The FDA cannot fulfill its mission because its
information technology (IT) infrastructure is
inadequate.
- The
Media and the Chemical Imbalance Theory of Depression,
by Jonathan Leo & Jeffrey R. Lacasse, Springer
Science, (2007)
-
Corporate Funding and Conflicts of Interest: A Primer
for Psychologists, by Wendy S. Pachter Washington,
Ronald E. Fox Human, Philip Zimbardo, and David O.
Antonuccio, American Psychologist (December
2007).
- Some
fear medicines may put foster kids' future health at
risk, by Gary Craig, Rochester Democrat and
Chronicle, December 10, 2007.
- Potent Pills: More foster kids getting mood-altering
drugs, by Gary Craig, Rochester Democrat and
Chronicle, December, 9, 2007.
- Prescription Abuse Seen In U.S. Nursing Homes: Powerful
Antipsychotics Used to Subdue Elderly; Huge Medicaid
Expense, by Lucette Lagnado, Wall Street Journal,
December 4, 2007, A1.
- The Media and the Chemical Imbalance Theory of
Depression, by Jonathan Leo & Jeffrey R. Lacasse,
Society, 2007.
- Complaint in
Arkansas v. Janssen Pharmaceutical Co. for Medicaid Fraud and
other claims, filed November 20, 2007.
- Drugs for ADHD
"Not the Answer," BBC, November 12, 2007.
- Psychiatry: 60 years in an increasingly corrupt
specialty, an interview with psychiatrist Nathaniel
Lehrman, November 11, 2007.
- Forced Drugging of Children in Foster Care: Turning
Child Abuse Victims into Involuntary Psychiatric
Patients, by M. McKay, Ph.D., Journal of
Orthomolecular Medicine, Vol. 22, No. 2, 2007
- Danger drugs designed for schizophrenics used to calm
children, by Fiona MaCrae, Daily Mail,
September 11, 2007.
- World
Experts Demand End to Child Drugging in the US - Part II,
by Evelyn Pringle, Lawyers & Settlements, October
27, 2007.
- World
Experts Demand End to Child Drugging in the US - Part I,
by Evelyn Pringle, Lawyers & Settlements, October
27, 2007.
- A
Systematic Review of Mortality in Schizophrenia: Is the
Differential Mortality Gap Worsening Over Time? by
Sukanta Saha, MSc, MCN; David Chant, PhD; John McGrath,
MD, PhD, Arch Gen Psychiatry,
2007;64(10):1123-1131.
- From Sweden--Reported
suicides – more than 80 percent got psychiatric drugs,
well over 50 percent got antidepressants, TransWorld News, October 7, 2007.
- Forced Drugging of Children in Foster Care: Turning
Child Abuse Victims into Involuntary Psychiatric
Patients, by M. McKay, Ph.D., JOM, Vol. 22,
No. 2 (2007).
-
Lilly Adds
Label Warnings for Mental Drug Zyprexa, by Alex
Berenson, New York Times, October 5, 2007
- Arkansas
Plans Lawsuit Over Antipsychotics, Pharmalot,
September 23rd, 2007, by Ed Silverman
- Worse Than
Vioxx: Zyprexa, Risperdal, Clozaril, And Paxil Killed
Thousands Of Americans, by Philip Dawdy,
Furious Seasons,
September 19, 2007.
- The Truth
is Not Free, by David Egilman, MD, the doctor from
who Jim Gottstein subpoenaed the
Zyprexa Papers, about his recent settlement with Eli
Lilly (Stipulation
and Order,
Affidavit), in Sequestered Science, September 11,
2007.
- Psychiatrists' Failure to
Inform: Is There Substantial Financial Exposure?, by
James B. Gottstein, Esq., Ethical Human Psychology
and Psychiatry, Vol 9, No. 2, 117-125 (2007).
- Attorney
Subpoenas J&J, AstraZeneca and Lilly for Hidden Antipsychotic Data Part
I, Evelyn Pringle, September 10, 2007, Lawyers and Settlements."
- Authorities
baffled at baby anti-depressant prescriptions,
September 10, 2007, StuffCo.NZ.
- Sidelining Safety — The
FDA's Inadequate Response to the IOM, by Sheila Weiss Smith, Ph.D.,
New England Journal of Medicine, 357:960-963 September 6, 2007,
Number 10.
- Biological
Psychiatry: A Practice in Search of a Science, by W. Joseph Wyatt &
Donna M. Midkiff, Behavior and Social Issues, 15, 132-151 (2006).
- The Future of
Drug Safety: Action Steps by Congress, by the Institute of
Medicine, September, 2006.
- American Kids Being
Drugged To Death, by Evelyn Pringle.
- Psychotropic Drug Makers Bankroll Prescribing Shrinks
Part II, Evelyn Pringle, September 2, 2007, Lawyers and Settlements."
- Psychotropic Drug Makers Bankroll Prescribing Shrinks
Part I, Evelyn Pringle, August 30, 2007, Lawyers and Settlements.",
Evelyn Pringle, Lawyers & Settlements,
August 22, 2007.
- The Lives they Left Behind:
Suitcases Cases from a State Hospital Attic, from Darby Penney
and Peter Stastny.
- Doctor, just a
little something for you: Complex sales strategies go way beyond
freebies, by By Melissa Healy, Los Angeles Times Staff Writer,
August 6, 2007
- The Right Rx for Sadness:
Drugs may be an easy choice but not a good one, by By Deborah Kotz,
US News & World Report, 7/29/07
- Ped Med: Kid use of mind medicines rising, by Lidia Wasowicz, UPI Senior
Science Writer, July 10, 2007.
- Psychiatrists Top List in Drug Maker Gifts, by
Gardiner Harris, New York Times, June 27, 2007.
- No MedGuide for
Zyprexa after Eleven Years of Death and Injury, by Evelyn Pringle,
Op Ed News, June 18, 2007.
- Backlash on
bipolar diagnoses in children: MGH psychiatrist's work stirs debate,
by Scott Allen Boston Globe, June 17, 2007.
- After Sanctions,
Doctors Get Drug Company Pay, by Gardiner Harris and Janet Roberts,
New York Times, June 3, 2007
- Anne Stanton,
Northern Exposure.
- Anne Stanton,
Northern Exposure
- Psych meds drove my son
crazy, Salon, May, 2007.
-
Psychotic Reactions And Medicaid: One Man's Quest To Learn The Truth:
Meet Ben Hansen, by Ed Silverman, Pharmalot, May 17, 2007.
- New York Times, Psychiatrists, Children and the Drug Industry's Role, May 10, 2007.
- United States Senate Finance Committee Staff
Report on Use
of Educational Grants by Pharmaceutical Companies, April, 2007.
-
Zyprexa Hole Gets Deeper,
by Evelyn Pringle, Lawyers & Settlements, May 1, 2007.
-
Following the Script: How Drug
Reps Make Friends and Influence Doctors, by Adriane Fugh-Berman and
Shahram Ahari, PLoS Medicine, Vol. 4, No. 4, 621-5 (April 2007).
- A National Survey of
Physician–Industry Relationships, by Eric G. Campbell, Ph.D.,
Russell L. Gruen, M.D., Ph.D., James Mountford, M.D., Lawrence G.
Miller, M.D., Paul D. Cleary, Ph.D., and David Blumenthal, M.D., M.P.P.,
New England Journal of Medicine, 356;17, 1742-1750 (2007)
-
Lilly Receives
Zyprexa Greetings From Capitol Hill, by Evelyn Pringle, April 27,
2007.
- New York Times,
U.S.
Wonders if Drug Data Was Accurate, by Alex Berenson, April 25, 2007.
-
DSM and the Death of Phenomenology in
America: An Example of Unintended Consequences, by Nancy C. Andreasen,
Schizophrenia Bulletin vol. 33 no. 1 pp. 108–112, 2007
-
Patients Diagnosed
Schizophrenic and Bipolar To Boost Seroquel Sales, by Evelyn Pringle,
April 11, 2007.
- Senator Grassley asks
for Zyprexa Papers and other documents, April 4, 2007.
-
In Some States, Maker
Oversees Use of Its Drug, by Stephanie Saul, New York Times,
March 23, 2007.
- Popular Zyprexa
linked to illnesses: Schizophrenia drug at center of lawsuit, The
Plain Dealer, March 17, 2007.
-
Lilly Fraudulently
Marketed Zyprexa, Montana Claims, by Margaret Cronin Fisk, Bloomberg
News, March 12, 2007.
-
Makers of Zyprexa
Risperdal and Seroquel Under Fire, by Evelyn Pringle, March 9, 2007.
-
Why
Clients Should Not Take Psychotherapists into Their Confidence, by Jim
Gottstein, ISPS-US Newsletter: Winter, 2006/2007, Volume 7, Issue 3.
-
Does compulsory or supervised community treatment reduce 'revolving door'
care? Legislation is inconsistent with recent evidence, by Stephen
Kisely and Leslie Anne Campbell, British Journal of Psychiatry, 197,
373-374 (2007)
- A Mix of Medicines
That Can Be Lethal, by Jane Brody, New York Times, February
27, 2007.
- Taking back
the FDA, by Marcia Angell, Boston Globe, February 26, 2007
-
Activists Take on Eli Lilly Over
Off-Label Sale of Zyprexa, by Evelyn Pringle, Op Ed News,
February 26, 2007.
- Off-Label Sales of SSRIs
Leads To More Litigation, by Evelyn Pringle, Op Ed News,
February 22, 2007.
-
Debate Over Children and Psychiatric Drugs, by Benedict Carey,
New York Times, February 15, 2007.
- February 14, 2007, New York Times,
Judge Rules Drug
Documents Must Be Returned to Eli Lilly, by Landon Thomas, Jr.
- February 8, 2007, Secrecy's
dangerous side effects: When legal settlements allow companies to hide their
mistakes, what we don't know can hurt us, by Richard Zitrin
- February 5, 2007, Nobody Buys Lilly's Innocence
Routine About Zyprexa, by Evelyn Pringle
- February 1, 2007, Zyprexa Injury Clock Keeps Ticking Away, by Evelyn Pringle.
- January 25, 2007, Eli
Lilly The Habitual Offender, by Evelyn Pringle.
- Comment: The Role of Litigation in
Defining Drug Risks, by Aaron S. Kesselheim, MD, JD and Jerry Avorn, MD, Journal of American Medical Association
(JAMA), JAMA, January 17,
2007—Vol 297, No. 3; 308-311.
- Neuroleptics – Effects, Risks, Education
and Treatment Contexts, by Volkmar Aderhold, presented at Institute for
Social Psychiatry at the University of Greifwald, 01/2007
-
States Study Marketing of Lilly
Pill, by Alex Berenson, New York Times, January 20, 2007.
-
Evidence Lacking To
Support Many Off-Label Uses Of Atypical Antipsychotics, Medical
News Today, January 18, 2007.
- Attorney Asks
Eli Lilly to Issue Warning on Zyprexa, by By Evelyn Pringle, Op
Ed News, January 14, 2007
- Public Has
Right To Know Secrets Revealed In Zyprexa Documents, by Evelyn
Pringle, Op Ed News, January 12, 2007
- New York Times, Lilly
to Pay Up to $500 Million to Settle Claims, by Alex Berenson,
January 4, 2007.
- New York Times, Mother Wonders if Psychosis Drug Helped Kill Son, by Alex Berenson,
January 4, 2007.
- PsychRights writes Eli Lilly on
December 27, 2006, requesting it send a "Dear Doctor" letter to all
health care professions "advising them Zyprexa should not be prescribed
to anyone who is not already taking it.
- Video of
former Eli Lilly drug rep talking about how they were instructed
to downplay Zyprexa's negative effects.
-
Court
Allows Eli Lilly To Bury Zyprexa Documents, by Evelyn Pringle, Op
Ed News, December 21, 2006.
- New York Times, Disparity Emerges in Lilly Data on Schizophrenia Drug, by Alex
Berenson, December 21, 2006.
- New York Times,
Court
Orders Lawyer to Return Documents About an Eli Lilly Drug, December
20, 2006.
- New York Times Editorial,
Playing Down the Risks of a
Drug: Internal documents offer persuasive evidence that Eli Lilly
engaged in questionable behavior to prop up its best-selling drug,
December 19, 2006. New York Times,
Drug Files Show
Maker Promoted Unapproved Use, December 18, 2006.
- New York Times, Eli Lilly Said to Play Down Risk of Top Pill, December 17, 2006.
- Ann Blake Tracy,
Ph.D's December 13, 2006 and and September 13, 2004 FDA testimony on
SSRI anti-depressants.
- Forced Drugging and Special
Services: A Holocaust in America’s Schools, by Dr. Salvatore Pizzuro,
Disability Policy Specialist
- NY TImes, Proof Is Scant on
Psychiatric Drug Mix for Young, by Gardiner Harris, November 23,
2006.
- Morbidity and Mortality in People
with Serious Mental Illness, by National Association of State Mental
Health Program Directors, October 2006. This study found that the rate of
serious morbidity (illness) and mortality (death) of people diagnosed
with serious mental illness has accelerated to the point where they are
now dying 25 years earlier than the general population. The
Executive Summary does not attribute this to psychiatric drugs, but the
body of the report is pretty clear that the major change is the advent
of the second generation neuroleptics, also misnomered "atypical
antipsychchotics" and the great increase in polypharmacy, the practice
of giving multiple psychiatric drugs to patients.
- Biological Psychiatry: A Practice in Search of a Science, by W.
Joseph Wyatt & Donna M. Midkiff, Behavior and Social Issues, 15,
132-151 (2006).
- What’s Wrong With a Child?
Psychiatrists Often Disagree, New York Times, November 11, 2006.
- The Other Side of
Psychopharmacology: A Review of the Literature, by Thomas L. Murray,
Jr., Journal of Mental Health Counseling, Volume 28/Number
4/October 2006/Pages 309–337
- Report on Multi-Faceted
Grass-Roots Efforts To Bring About Meaningful Change To Alaska's Mental
Health Program
- The Other Youth Drug Problem,
Alternative Medicine, December, 2006.
- Soteria – a treatment model and a
reform movement in psychiatry, by Volkmar Aderhold - Translated by
Peter Stastny - September 2006, In honour of Loren Mosher.
- Uphill Battle-Warning Pharma Customers
About Dangers of SSRIs
- Drug Interactions Financial Ties to
Industry Cloud Major Depression Study, Wall Street Journal,
July 11, 2006.
- Antipsychotic Prescriptions Rise
Sharply for Children and Adolescents, National Institute of Mental
Health, June 2006.
- Commercial bias in medical journals: Commercial influence and the
content of medical journals, by Joel Lexchin, Donald W Light, British Medical Journal, 2006; 332:1444-7.
- Congruencies in Increased
Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public
Mental Health Clients in Eight States. by Craig W. Colton, PhD, Ronald W.
Manderscheid, PhD, Preventing Chronic Disease, Volume 3: No. 2, April
2006. This study found deceased public mental health clients had died at
much younger ages and lost decades of potential life when compared with their
living cohorts nationwide. Clients with major mental illness diagnoses died at
younger ages and lost more years of life than people with non-major mental
illness diagnoses.
- BBC July 1, 2006, article on Clozapine,
Schizophrenia drug 'health risk'.
- In Diabetes, One More Burden for the
Mentally Ill, New York Times, June 12, 2006.
- The Plan to Drug
America's School Children: The President’s New Freedom Commission On
Mental Health, by George Stone, MA, MSW
- Why is it so difficult to stop
psychiatric drug treatment? It may be nothing to do with the original
problem, by Joanna Moncrieff, Medical Hypothesis, 2006.
- Outrage! Preschoolers used
as guinea pigs in psychotropic drug tests, by Mike Adams, Natural
News, May 18, 2006.
- Open Letter to Sally Satel
from Michael Allen, Senior Staff Attorney, Bazelon Center for Mental
Health Law, May 5, 2006.
- Comparison of Schizophrenia Drugs Often Favors Firm Funding Study,
Washington Post, Wednesday, April 12, 2006
- ADHD, Drug
Labels, and the FDA: The Continuing Pre-Emption of Public Health, by
Grace E. Jackson, MD., March 28, 2006
- FDA Urges
Stronger Warnings on ADHD Drugs, Wall Street Journal, March
15, 2006.
- Special Report:
Court Filing Makes Public My Previously Suppressed Analysis of Paxil’s
Effects, by Peter R. Breggin, MD, Ethical Human Psychology and
Psychiatry, Volume 8, Number 1, Spring 2006, 77-84.
- Full
Report (sworn written testimony filed in the Lacuzong Case).
- Lifetime
suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts
compared, by D. Healy, M. Harris, R. Tranter, P. Gutting, R. Austin,
G. Jones-Edwards and A.P. Roberts, British Journal of Psychiatry (2006),
188, 223-228. This study documents how the suicide rate went from
one half of one percent before the advent of neuroleptics (and
deinstitutionalization) to four percent in the modern era where
neuroleptics are the standard treatment.
- The
Gaithersburg Address: ADHD Medications: Risks and Benefits, Sue
Parry's Testimony to the FDA, February 9, 2006.
- The latest mania:
Selling bipolar disorder, by D. Healy, PLoS Med 3(4): e185
(2006).
- The Under Reported Story: ADHD,
Stimulants, and the FDA, by Grace E. Jackson, MD, February 18, 2006.
- Associated Press, February 10, 2006:
FDA Panel recommends "Black
Box" warning regarding lethal potential of ADHC Drugs (Ritalin, etc.).
- Trends in Prescribing of
Antipsychotic Medications for US Children, by William O. Cooper, MD,
MPH; Patrick G. Arbogast, PhD; Hua Ding, MS; Gerald B. Hickson, MD; D.
Catherine Fuchs, MD; Wayne A. Ray, PhD, Ambulatory Pediatrics,
2006;6:79–83, documents the astonishing increase in prescriptions of
neuroleptics to children.
-
FDA Urges Stronger
Warnings on ADHD Drugs, Wall Street Journal, March 15, 2006.
-
Stimulant
Treatment of ADD/ADHD: Concerns about Adverse Effects, DuBose
Ravenel, M.D., F.A.A.P., written testimony to FDA for March 22, 2006
Pediatric Committee Meeting.
- The Australian:
Dark side of a wonder drug, March 28,
2006.
- The Age (Australia):
Children on ADHD drugs suffer strokes, March 27, 2006.
-
ADHD: The new stimulant threat, An estimated six
million of our children are taking powerful prescription amphetamines
known to speed freaks as the champagne of uppers.
-
Attention Surplus? Re-examining a
Disorder, by Paul Steinberg, MD, New York Times, March 7, 2006.
-
Disposition of Emergency Department
Visits for Drug-Related Suicide Attempts by Adolescents: 2004,
February, 2006, by the Drug Abuse Warning Network (DAWN), in
Office of Applied Studies (OAS), Substance Abuse and Mental Health
Services Administration (SAMHSA). This review of emergency room
visits found that over 40% of the over 15,000 adolescent suicide
attempts resulting in emergency room visits in 2004 involved psychiatric
drugs.
- Medication-Free Research in Early Episode
Schizophrenia: Evidence of Long-Term Harm? by John R. Bola,
Schizophrenia Bulletin vol. 32 no. 2 pp. 288–296, 2006, doi:10.1093/schbul/sbj019.
-
The Under Reported Story: ADHD,
Stimulants, and the FDA, by Grace E. Jackson, MD, February 18, 2006.
- Associated Press, February 10, 2006:
FDA Panel recommends "Black Box" warning regarding lethal potential of
ADHC Drugs (Ritalin, etc.).
-
Pediatric bipolar disorder: An object of study in the
creation of an illness, by David Healy and Joanna Le
Noury, International Journal of Risk & Safety in
Medicine, 19 (2007) 209–221.
- Sedative
hypnotics in older people with insomnia: meta-analysis of risks and
benefits, by Jennifer Glass, Krista L Lanctôt, Nathan Herrmann, Beth
A Sproule, Usoa E Busto, British Medical Journal, BMJ,
doi:10.1136/bmj.38623.768588.47 (published 11 November 2005).
-
Childhood
trauma, psychosis and schizophrenia: a literature review with
theoretical and clinical implications, ACTA Psychiatrica
Scandinavica, 2005: 112: 330–350
- Zyprexa
IM Caution Issued in Some Countries But Not U.S, by Mark Moran,
Psychiatric News, April 15, 2005, Vol. 40 No. 8.
-
Consumer
Advertising of Psychiatric Medications Bias Public Against
Non-pharmocological Treatment, by Jeffrey R. Lacasse, Ethical Human Psychology and Psychiatry, Vol. 7, No. 3, Fall/Winter
2005.
- Mental Illness and the
Freedom to Refuse Treatment: Privilege or Right, by Ron Bassman, Professional Psychology: Research and Practice, 2005, Vol 36, No. 5,
488-497.
-
Confidential Master Settlement Agreement in
Zyprexa I,
filed with the Securities and Exchange Commission, November 3, 2005.
-
Trouble in
Prozac Nation, Fortune Magazine, November 2005.
-
Bitter
Pills: They're prescribed to millions, but
do the new antidepressants work? And are they worth the risk?
Time Magazine, Asia Edition, November 14, 2005.
- How the
Legal System Can Help Create a Recovery Culture in Mental Health Systems,
- New Drugs, New Problems, by Dr.
Yolande Lucire, Australian Journal of Forensic Sciences, 37:1, in Press as of
November 6, 2005.
- Rethinking schizophrenia:
its original nature, its drug-altered character, and thoughts about its
treatment, by Nathaniel S. Lehrman,
M.D., presented at the International Center for the Study of Psychiatry
and Psychology (ICSPP) October, 2005, Conference.
-
Drug Secrets: What the FDA
isn't telling, Slate, September 27, 2005, by Jeanne Lenzer.
-
GPs
to stop prescribing antidepressants blamed for suicidal feelings in
under-18s, The Guardian (UK), September 28, 2005.
-
Little Difference Found in
Schizophrenia Drugs, The New York Times, and
Generic Fares Well In Big Psychiatry
Study: Newer, Costlier Drugs Have Little Advantage for
Schizophrenia;Comparative Data on Side Effects in the Wall Street
Journal September 20, 2005, discuss the just released study from the
New England Journal of
Medicine,
Effectiveness of Antipsychotic Drugs in Patients with Chronic
Schizophrenia, demonstrating little if any more benefit or fewer
problems with the so-called "atypical" neuroleptics, such as Zyprexa,
Risperdal, Geodon, and Seroquel that cost so much more over the older
ones, such as Thorazine, Haldol, Prolixin and Navane.
-
First trimester antidepressant
risk, from Australian Dr., describes SSRIs doubling the risk of
birth defects if used during pregnancy.
-
New
Antipsychotic Drugs Worrying, new study shows, Globe and Mail,
September 13, 2005.
- Are ADHD drugs safe? Report
finds little proof, Tacoma Tribune, September 13th, 2005, reports
the most comprehensive scientific analysis of the drugs to date has
found little evidence that they are safe, that one drug is more
effective than another or that they help school performance.
- Anatomy of an Epidemic:
Psychiatric Drugs and the Astonishing Rise of Mental Illness in America,
by Robert Whitaker, Ethical Human Psychology and Psychiatry,
Volume 7, Number I: 23-35 Spring 2005.
-
My Whole Body is Sick . . . My Life is
Not Good: A Rwandan asylum seeker attends a psychiatric clinic in
London, by Derek Summerfield, Ch. 6 from: Forced Migration and
Mental Health. Rethinking the Care of Refugees and Displaced Persons (ed
D. Ingleby) New York: Springer 2005.
-
Top-selling drug
(Seroxat/Paxil) linked to increased suicide risk, London Times,
August 22, 2005.
- Bay Area Street Smart's August, 2005 series on psychiatric abuses.
- Officials Bicker as Mentally Ill
Wither, Los Angeles Times, August 3, 2005.
-
Context and Cooperation in
Strategic Therapy: Toward a Contextual Mental Health (Draft Copy
July 28, 2005) by
George Stone, MA, MSW. -
Huge Mental Health Victory
for MN Families: MN parents & children protected from mental health coercion &
universal screening, Edwatch, July 18, 2005
-
How to Quit the Cure, Newsweek, August 8, 2005.
-
Death of the Magic Bullet,
Sunday (London) Times, July 31, 2005.
-
Bitter Pill, in Columbia Journalism
Review, August 2005, describes the Media's contributing role to
false and misleading information about the safety and benefits of new
drugs.
- A Curious Consensus:
“Brain Scans Prove Disease?” By Grace E. Jackson, MD, July 10, 2005 (Revised
Sept. 2005)
- Stefan P Kruszewski:
Schizophrenia and Epilepsy: Untenable Link from Flawed Research Design
(5 July 2005) responding to Ping Qin, Huilan Xu, Thomas Munk
Laursen, Mogens Vestergaard, and Preben Bo Mortensen, Risk for
schizophrenia and schizophrenia-like psychosis among patients with
epilepsy: population based cohort study BMJ 2005; 331: 23.
- Three Part Washington Post Series by Shankar Vedantam on Mind and
Culture: Psychiatry's Missing Diagnosis
- June 1, 2005, Freedom of
Information Act transmittal of Adverse Reactions to Olanzapine (Zyprexa).
(13 MB)
- The Marketization of Depression: Prescribing SSRI
Antidepressants to Women, by Janet Currie, Women and Health Protection,
May 2005.
- House of Commons Health
Committee: The Influence of the Pharmaceutical Industry, March 22, 2005.
-
What Can We Learn from Medical
Whistleblowers? Their experiences paint a troubling picture of American
medicine's ties with the pharmaceutical industry, by Jeanne Lenzer in the
Public Library of Science (PLOS), May 27, 2005, Volume 2, Issue 7.
- The Ethics of Electroconvulsive Therapy (ECT)
by Loren R. Mosher MD and David Cohen, PhD, Journal of the American Medical
Association October 2003, Volume 5, Number 10
- The Influence of Big Pharma: Wide Ranging
Report Identifies Many Areas of Influence and Distortion, British Medical
Journal, April 16, 2005, BMJ 2005;330:857–8
-
Opportunity cost of antidepressant prescribing in
England: analysis of routine data, by Sandra Hollinghurst, David Kessler,
Tim J Peters, David Gunnell, British Medical Journal (BMJ), BMJ,
doi:10.1136/bmj.38377.715799.F7 (published 18 March 2005)
- In its February 19, 2005, issue, the
British Medical Journal (BMJ)
published three articles about SSRI Antidepressants and suicide.
- Randomized Controlled Trials:
Evidence Biased Psychiatry, By David Healy, MD MRCPsych
- An Examination of Eli Lilly and Company's
Contentions that the BMJ Prozac Documents were Never Missing and Have No
Significance, by Dr. Peter Breggin, January 12, 2005.
-
Dr. Grace Jackson's
June 6, 2004 Public Lecture, "What Doctors May Not Tell You About
Psychiatric Drugs," to the UCE Centre for Community Mental Health,
in Birmingham, England.
- California Court bans electroshock at Santa Barbara College Hospital on January
5, 2005 in Akkerman v.
Johnson.
- PsychRights 2004 Year-End Report.
-
FDA Scientists Issued Early
Warnings on Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr.
Graham in Senate
- In Re: Robert S,
November 18, 2004, Illinois Supreme Court Opinion holding the State of Illinois
violated Robert's constitutional rights, as a pretrial detainee in a forced
medication proceeding based on his purported best interests, by not notifying
his criminal defense attorney and failing to appoint a psychiatrist as an
independent expert witness, rather than a psychologist.
- PsychRights Joins MindFreedom Shield Program
- National Mental Health Screening
of children effort likely to be orchestrated by drug companies to
increase percentage of kids on psychiatric drugs.
- Mental Health "Parity": Why Waste
Money, Endanger Civil Liberties? Special to The Seattle Times, Thursday,
February 10, 2005, By Keith Hoeller
- Ontario Electroshock ("ECT") Statistics
2000-2002 (third draft), compiled by Don Weitz.
- International Consensus: ADHD and
Abuse in the Prescription of Psychopharmaceutical Drugs to Minors (January
2005) "Giu' Le Mani Dai Bambini®" National
Campaign for the Defence of Children's Right to Health.
-
Drug firms lagging on openness: Despite vow, few studies publicized, Boston
Globe, January 9, 2005.
- The Prozac Paradox: Why
antidepressants may exacerbate depression and anxiety in some kids and teens,
Popular Science, January 2005.
- The Dictionary of Disorder, by Alix Spiegel: How
one man revolutionized psychiatry, The New Yorker, January 3, 2005, posted
December 27, 2004.
- FDA to Review "Missing" Drug Company
Documents, British Medical Journal, December 31, 2004, BMJ VOLUME
330 1 JANUARY 2005 bmj.com.
- FDA Scientists Issued Early Warnings on
Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr. Graham in
Senate Testimony, Union of Concerned Scientists, December, 2004.
- Dr. Joseph Glenmullen's Q&A from ABC News on
Anti-Depressants.
- At F.D.A., Strong Drug Ties and
Less Monitoring, New York Times, December 6, 2004.
- Scientific
American Mind, December 2004 Issue, Treating Depression: Pills or Talk?
- Crisis deepens at the US Food and Drug
Administration, British Medical Journal, December 4, 2004, BMJ
2004;329:1308 (4 December), doi:10.1136/bmj.329.7478.1308
- Contracts Keep Drug Research Out of Reach, New York Times, November 29,
2004.
- Public interest group accuses FDA of trying to
discredit whistleblower, British Medical Journal, November 27, 2004
- Forbes: Antidepressants Tied to Abnormal
Bleeding
-
Minutes of Evidence, United Kingdom Parliament, House of Commons, Select
Committee on Health, October 14, 2004.
- New York Times
Magazing, November 21, 2004, The Antidepressant Dilemma.
- Stun gun deaths raise
drug-link questions, Sacramento Bee, November 13, 2004
- Bush's plan to screen for
mental health meets opposition in Illinois, British Medical Journal,
November 6, 2004.
- Biomedical Bias of the American
Psychiatric Association, by Duncan B. Double, MA, MRCPsych. This is
an academic article that deconstructs the American Psychiatric Association's
September, 2003 "Statement"
responding to the
Fast for
Freedom in Mental Health.
- Psychiatric Fraud and Force: A Critique of E.
Fuller Torrey, by Thomas Szasz, M.D., 416 Journal of Humanistic
Psychology, Vol. 44 No. 4, Fall 2004 416-430.
- 2004 letter responding to assertions that (1)
ADHD is generally considered to be a neurochemical disorder, (2) ADHD is
present from birth, and (3)
ADHD is not caused by poor parenting, dysfunctional families, poor schooling
or nutrition.
- Did major media outlets fail to ask
the right questions about depression study? British Medical Journal,
September 25, 2004.
-
Seroxat (Paxil) and Prozac 'can make people homicidal,' The Guardian,
September 21, 2004.
- Bush Wants to Screen All
Children for Mental Illness, by Keith Hoeller, Ph.D., September 19, 2004,
editor of Review of
Existential Psychology & Psychiatry.
- Presentation before the FDA on September
13, 2004, Lawrence Diller, M.D.
- FDA Urged Withholding
Data on Antidepressants Makers Were Dissuaded From Labeling Drugs as
Ineffective in Children, Washington Post, Friday, September 10, 2004.
- A Commentary on the Proposal to Observe the
Effects Of a Single Dose of Amphetamine in Children, by Jonathan Leo,
Ph.D., Submitted for the Food and Drug Administration’s Meeting of the
Pediatrics Ethics Subcommittee of the Pediatric Advisory Committee on
September 10, 2004.
- Journals Insist Drug
Manufacturers Register All Trials, in the Washington Post, September
8, 2004
- GlaxoSmithKline Settles NY Fraud Suit, promising to disclose all drug
trial results, August 26, 2004. See,
Consent Decree
(Settlement) and
Press
Release.
- Prozac Nation: Is the Party
Over? By Richard C. Morais, Forbes, August 20, 2004.
- Bush plans to screen whole US
population for mental illness, Jeanne Lenzer New York British Medical Journal,
Vol. 328, 19 June 2004, page 1458, bmj.com (PDF
Version).
-
Secret US report surfaces on antidepressants in children, by Jeanne
Lenzer New York, British Medical Journal, Vol.329 7 AUGUST 2004,
page 307 bmj.com.
- Janssen, July
21, 2004 "Dear Health Care Provider" Letter for Risperidone (Risperdal).
- April 19, 2004, FDA
Warning Letter to Janssen about its previous Dear Health Care Provider
being "false or misleading," which resulted in the July 21, 2004 letter.
-
Clinical Trials Controversy Spotlights Flawed System, by Jim Rosack,
Psychiatric News July 16, 2004, Volume 39 Number 14.
- July 2, 2004, Pennsylvania
whistleblower lawsuit by Harvard trained psychiatrist Stefan P.
Kruszewski, in Pennsylvania over Drug company/Pennsylvania State
corruption involving drugging abuses, including deaths of children.
- Psychiatric Polypharmacy: A Word of
Caution, June 2004, Protection and Advocacy, Inc.
- FDA Revisits Issue Of Antidepressants for
Youths: New Analysis May Pressure Agency to Set Limit on Use Because of
Suicide Risk, by Anna Wilde Mathews, Wall Street Journal, August 5,
2004; Page A1.
- The Biology of Mental Illness,
by Jonathon Leo in Society, July/August 2004. Dr. Leo goes
through the lack of any evidence supporting the current conventional
wisdom that mental illness is an actual disease.
- FDA’s counsel accused of
being too close to drug industry, Jeanne Lenzer New York, BMJ VOLUME
329 24 JULY 2004.
- Mum free after murder bid.
- Eli Lilly, Zyprexa and the Bush
Family, by Bruce Levine in Z Magazine Online, May 2004 Volume 17
Number 5
- The evidence base: rock of
certainty or shifting sands? by John Dewhurst, retired pharmaceutical
physician, British Medical Journal, April 17, 2004, BMJ 2004;328:963 (17
April), doi:10.1136/bmj.328.7445.963
- All the Things They
Taught Us That Were Wrong, by Thomas A. M. Kramer, MD Psychopharmacology Today,
2004;6(2):e19.
- Interview of Dr. Loren Mosher in the
April 2004 issue of Mental Health Today (UK).
- LA Times, April 6, 2004:
FDA Sat on Report Linking Suicide, Drugs
- New York Times'
February 25, 2004 article on Eli Lilly and Zyprexa, which includes that
"In the last year, doctors have learned that its side effects include
diabetes, stroke and death."
- Allen Jones' Full
Whistle-Blower Report on Drug Company influence on states' drug purchases.
- Drug report barred by
FDA/Scientist links antidepressants to suicide in kids, Sunday, February
1, 2004 (SF Chronicle), Rob Waters, Special to The Chronicle
- Talking back to
Prozac: David Healy was among the first psychiatrists to prescribe Prozac. Now
he's one of the fiercest critics of Big Pharma's "marketing" of depression.
Did his outspoken views cost him his job? By Joshua Kendall, The Boston
Globe, 2/1/2004
- Antidepressants & Suicide:
Lawsuits target drug makers, New Jersey Star-Ledger, Friday, January 30, 2004.
- Antidepressant Makers
Withhold Data on Children, washingtonpost.com, By Shankar Vedantam,
Washington Post Staff Writer, Thursday, January 29, 2004; Page A01
- Oh, behave! By
Joe Studwell Financial Times, Published: January 23 2004
- Allen Jones May 8, 2004,
lawsuit against the Pennsylvania Inspector General's office over
retaliation for filing a previous civil rights action and for speaking out
about corruption in
Pennsylvania's psychiatric drug purchases.
- A
Suicide Side Effect? What parents aren't being told about their kids'
antidepressants. San Francisco Chronicle, January 4, 2004.
- The Limits of
Psychiatry, by Duncan Double, British Medical Journal, Vol
324: 900-904, April 15 2002.
- The psychiatric protection
order for the “battered mental patient,” by Thomas Szasz. BMJ (British
Medical Journal) Vol. 327 20–27 December 2003, 1449-51.
- How Drug Directory Helps Raise Tab for
Medicaid and Insurers: They Pay for "Off Label" Uses if Listed -- and
Drugdex Lists Great Many of Them, by David Armstrong, The Wall Street
Journal, October 23, 2003.
- Over-medication: a growing crisis: Aggressive marketing a major culprit,
By Lou Dobbs. October 2, 2003.
- Does
Medicaid Pay Too Much for Prescription Drugs? A Case Study of Atypical
Anti-Psychotics, by Mark Duggan, University of Chicago and NBER
- Is it Prozac or Placebo.
- Psychiatric
Medications, Illicit Drugs, & Alcohol, By Bruce Levine
- Frontline
Investigates whether FDA Assuring Drug Safety.
- Civil Commitment Due
To Mental Illness And Dangerousness: The Union Of Law And Psychiatry Within A
Treatment-Control System, by Bernadette Dallaire, Michael McCubbin, Paul
Morin, and David Cohen, Sociology of Health & Illness; Sep2000, Vol.
22 Issue 5, p679, 21p
- Involuntary Psychiatric
Interventions A Breach of the Hippocratic Oath? by Peter Stastny, MD, Ethical Human Sciences and Services,
Vo. 2, No. 1: 21-41 (2000)
- SSRI discontinuation syndrome
in Postgraduate Medicine
- Treatment-induced
Suicide: Suicidality as a potential effect of psychiatric drugs, by
Peter Lehman in, Journal of Critical Psychology, Counselling and
Therepy, Vol 2, No. 1, (Spring 2002).
- The Invention of
Post-Traumatic Stress Disorder and the Social Usefulness of a
Psychiatric Category, by Derek Summerfield, British Medical
Journal, January 15, 2001, Vol 322: 95-98.
- "What if ADHD Really
Doesn't Exist?" by: Tony Zizza, AbleChild.org
- Critique of Medical-Coercive Psychiatry by
Ron Leifer M.D.
- Coercive
psychiatry, human rights and public participation by Richard Gosden
- The Effects of Medicating or Not
Medicating on the Treatment Process by Bertram P. Karon, Ph.D.
- Three Part Series: Problems With Forced Psych Drug Treatment, by Nicholas Regush
- Trauma Within the Psychiatric Setting: A Preliminary Empirical
Report, by Karen J. Cusack, B. Christopher Frueh, Thom Hiers, Samantha
Suffoletta-Maierle, and Sandy Bennett, Administration and Policy in
Mental Health, Vol. 30, No. 5, May 2003 (2003)
- Unwarranted Court Ordered
Medication: A Call to Action
- The Other Drug War: Big Pharma’s 625 Washington
Lobbyists from Public Citizen, July 2001.
- The Right to Refuse Treatment by Grace E.
Jackson, MD
- Therapeutic
Jurisprudence: Embracing a Tainted Ideal, by Arthur G. Christean
- ADHD: Total, 100%
Fraud, by Fred A. Baughman Jr., Neurologist, Pediatric Neurologist,
Fellow, American Academy of Neurology
- Insanity Pleas in the City Limits
Monthly, May 2000.
- The
MacArthur Coercion Study Executive Summary February 2001
- Mandated Community
Treatment: Beyond Outpatient Commitment, by John Monahan, Ph.D, Richard J.
Bonnie, LL.B, Paul S. Appelbaum, M.D., Pamela S. Hyde, J.D., Henry J.
Steadman, Ph.D., and Marvin S. Swartz, M.D.
- The Rights of Users of the Mental
Health System: The Tight Knot of Power, Law, and Ethics, by Michael
McCubbin & David Cohen - June 1999.
- Do
Psychiatric Inmates in New York Have the Right to Refuse Drugs? An
Examination of Rivers Hearings in the Brooklyn Court
- Why Psychiatric Drugs Are
Always Bad by Douglas C. Smith, M.D
- The Bureaucratic Destruction of
Patients' Faith in Their Doctors: Public Psychiatry's Negative Lessons
for General Medicine, by Nathaniel S. Lehrman, Bulletin of the New York
Academy of Medicine, Winter 1994, Vol. 71, No. 2; 194-217.
-
A Critical Analysis of the Minimal Brain Dysfunction Syndrome, by T.
Richard Saunders, Professional Psychology, June 1979: 293-306.
-
Hyperactive Children and the Use of Psychoactive Drugs: Treatment or
Coercive Behavior Management?, by Douglas W. Springmeyer, Journal
of Contemporary Law, Vol. 5:215-231 (1979)
- Twenty-Nine Medical Causes of
“Schizophrenia,” Excerpted from Nutrition and Mental Illness, by the
late Carl C. Pfeiffer, Ph.D., M.D.
- On Being Sane In Insane Places, by David L.
Rosenham, Science, Vol. 179 (Jan. 1973), 250-258. This is the
classic study where eight of Rosenhan's friends and grad students posed as mentally ill and the psychiatrists
couldn't tell (but the other patients could).
FAIR USE NOTICE: These links may contain copyrighted (© ) material the use of
which has not always been specifically authorized by the copyright owner. Such
material is made available to advance understanding of ecological, political,
human rights, economic, democracy, scientific, moral, ethical, and social
justice issues, etc. It is believed that this constitutes a 'fair use' of any
such copyrighted material as provided for in section 107 of the US Copyright
Law. In accordance with Title 17 U.S.C. Section 107, this material is used for
non-profit educational purposes. For more information go to:
http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use
copyrighted material for purposes of your own that go beyond 'fair use', you
must obtain permission from the copyright owner. Any copyright owner who
objects to the use of their copyrighted material should send an e-mail to
webmaster@psychrights.org.
Last modified June 8, 2024
Copyright © 2003-2025 Law Project for Psychiatric Rights. All Rights Reserved
